Trizetto (TZIX) 10-Q 2006 Q2 Quarterly report

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2006

OR

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                    to                    

Commission file number 000-27501

The TriZetto Group, Inc.

(Exact Name of Registrant as Specified in Its Charter)

Delaware	33-0761159
(State or Other Jurisdiction of Incorporation or Organization)	(I.R.S. Employer Identification Number)

567 San Nicolas Drive, Suite 360 Newport Beach, California	92660
(Address of Principal Executive Offices)	(Zip Code)

Registrant’s telephone number, including area code: (949) 719-2200

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  x    No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer or a non-accelerated filer. See definition of “accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange Act.

Large accelerated filer  ¨                Accelerated filer  x                Non-accelerated filer  ¨

Indicated by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  ¨    No  x

As of August 2, 2006, 43,075,894 shares, $0.001 par value per share, of the registrant’s common stock were outstanding.

THE TRIZETTO GROUP, INC.

QUARTERLY REPORT ON

FORM 10-Q

For the Quarterly Period Ended June 30, 2006

TABLE OF CONTENTS

	PAGE
PART I—FINANCIAL INFORMATION
Item 1 Financial Statements:
Condensed Consolidated Balance Sheets as of June 30, 2006 (unaudited) and December 31, 2005	1
Unaudited Condensed Consolidated Statements of Operations for the Three and Six Months Ended June 30, 2006 and 2005	2
Unaudited Condensed Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2006 and 2005	3
Notes to Unaudited Condensed Consolidated Financial Statements	4
Item 2Management’s Discussion and Analysis of Financial Condition and Results of Operations	10
Item 3Quantitative and Qualitative Disclosures about Market Risk	21
Item 4Controls and Procedures	21
PART II—OTHER INFORMATION
Item 1Legal Proceedings	22
Item 1ARisk Factors	23
Item 4Submission of Matters to a Vote of Security Holders	32
Item 6Exhibits	33
SIGNATURES	34

i

PART I — FINANCIAL INFORMATION

Item 1. Financial Statements

The TriZetto Group, Inc.

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands)

	June 30, 2006			December 31, 2005
	(unaudited)
Assets
Current assets:
Cash and cash equivalents	$	75,495		$	106,940
Restricted cash		992			1,543
Accounts receivable, less allowances of $1,808 and $855 at June 30, 2006 and December 31, 2005, respectively		62,081			41,745
Prepaid expenses and other current assets		10,299			11,059
Deferred tax assets		406			—
Income tax receivable		422			316
Total current assets		149,695			161,603
Property and equipment, net		25,425			25,730
Capitalized software development costs, net		28,804			28,724
Goodwill		75,545			87,170
Other intangible assets, net		30,058			3,335
Other assets		10,633			11,177
Total assets	$	320,160		$	317,739
Liabilities and Stockholders’ Equity
Current liabilities:
Notes payable	$	754		$	120
Current portion of capital lease obligations		1,029			1,979
Accounts payable		12,001			14,959
Accrued liabilities		27,591			56,957
Deferred revenue		43,027			35,625
Total current liabilities		84,402			109,640
Long-term convertible debt		100,000			100,000
Long-term revolving line of credit		4,000			—
Other long-term liabilities		1,984			1,752
Capital lease obligations		674			1,065
Deferred revenue		4,026			3,924
Total liabilities		195,086			216,381
Commitments and contingencies
Stockholders’ equity:
Common stock		44			42
Additional paid-in capital		369,662			362,186
Deferred stock compensation		—			(2,986	)
Accumulated deficit		(244,632	)		(257,884	)
Total stockholders’ equity		125,074			101,358
Total liabilities and stockholders’ equity	$	320,160		$	317,739

See accompanying notes.

1

The TriZetto Group, Inc.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data)

(unaudited)

	Three Months Ended June 30,						Six Months Ended June 30,
	2006			2005			2006			2005
Revenue:
Recurring revenue	$	43,677		$	40,116		$	87,387		$	79,139
Non-recurring revenue		44,033			32,392			85,641			65,187
Total revenue		87,710			72,508			173,028			144,326
Cost of revenue:
Recurring revenue		23,803			24,769			49,498			48,167
Non-recurring revenue		21,409			17,214			40,535			33,425
		45,212			41,983			90,033			81,592
Recurring revenue – loss on contracts		—			(2,877	)		—			(2,877	)
Total cost of revenue		45,212			39,106			90,033			78,715
Gross profit		42,498			33,402			82,995			65,611
Operating expenses:
Research and development		10,743			8,434			21,221			16,915
Selling, general and administrative		24,027			18,775			45,343			36,877
Amortization of other intangible assets		1,068			857			2,576			1,740
Total operating expenses		35,838			28,066			69,140			55,532
Income from operations		6,660			5,336			13,855			10,079
Interest income		945			182			1,835			371
Interest expense		(835	)		(178	)		(1,667	)		(537	)
Other income		—			—			180			—
Income before provision for income taxes		6,770			5,340			14,203			9,913
Provision for income taxes		(356	)		(361	)		(951	)		(636	)
Net income	$	6,414		$	4,979		$	13,252		$	9,277
Net income per share:
Basic	$	0.15		$	0.12		$	0.31		$	0.22
Diluted	$	0.14		$	0.11		$	0.29		$	0.21
Shares used in computing net income per share:
Basic		42,370			41,988			42,140			41,852
Diluted		45,394			44,816			45,548			44,383

The amounts included in the three and six months ended June 30, 2006 reflect the adoption of Financial Accounting Standards Board (“FASB”) Statement No. 123R,Share-Based Payment, effective January 1, 2006. Had TriZetto applied the provisions of FASB Statement No. 123R in prior periods, it would have reported net income of approximately $3.7 million or $0.09 per share basic and $0.08 per share diluted in the three months ended June 30, 2005, and net income of $6.1 million or $0.15 per share basic and $0.14 per share diluted in the six months ended June 30, 2005. See Note 3 of Notes to Unaudited Condensed Consolidated Financial Statements.

See accompanying notes.

2

The TriZetto Group, Inc.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

(unaudited)

	Six Months Ended June 30,
	2006			2005
Cash flows from operating activities:
Net income	$	13,252		$	9,277
Adjustments to reconcile net income to net cash provided by operating activities:
Provision for (benefit from) doubtful accounts and sales allowance		731			(612	)
Stock-based compensation		3,544			544
Depreciation and amortization		11,064			11,501
Amortization of other intangible assets		2,576			1,740
Deferred tax benefit		(406	)		—
(Gain) loss on disposal of assets		(158	)		37
Increase in cash surrender value of life insurance policies		(596	)		—
Loss on contracts		—			(2,877	)
Changes in assets and liabilities:
Restricted cash		551			(89	)
Accounts receivable		(21,067	)		7,834
Prepaid expenses and other current assets		(426	)		(2,223	)
Income tax receivable		(106	)		92
Notes receivable		5			29
Other assets		1,140			(1,982	)
Accounts payable		(839	)		(1,479	)
Accrued liabilities		(5,200	)		(9,490	)
Deferred revenue		7,504			623
Net cash provided by operating activities		11,569			12,925
Cash flows from investing activities:
Sale of short-term investments, net		—			1,203
Purchase of property and equipment and software licenses		(6,252	)		(1,640	)
Capitalization of software development costs		(4,605	)		(4,124	)
Acquisition, net of cash acquired		(42,370	)		—
Net cash used in investing activities		(53,227	)		(4,561	)
Cash flows from financing activities:
Proceeds from revolving line of credit		19,000			39,000
Proceeds from debt financing		992			1,511
Payments on revolving line of credit		(15,000	)		(28,000	)
Payments on notes payable		(359	)		(38,161	)
Payments on capital leases		(1,341	)		(2,514	)
Employee exercises of stock options and purchase of common stock		6,921			4,118
Net cash provided by (used in) financing activities		10,213			(24,046	)
Net decrease in cash and cash equivalents		(31,445	)		(15,682	)
Cash and cash equivalents at beginning of period		106,940			70,489
Cash and cash equivalents at end of period	$	75,495		$	54,807

See accompanying notes.

3

The TriZetto Group, Inc.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

1. Basis of Preparation

The accompanying unaudited condensed consolidated financial statements have been prepared by The TriZetto Group, Inc. (the “Company”) in accordance with generally accepted accounting principles for interim financial information that are consistent in all material respects with those applied in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2005, and pursuant to the instructions to Form 10-Q and Article 10 promulgated by Regulation S-X of the Securities and Exchange Commission (the “SEC”). Accordingly, they do not include all of the information and notes to financial statements required by U.S. generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the six months ended June 30, 2006, are not necessarily indicative of the results that may be expected for the year ending December 31, 2006, or for any future period. The financial statements and notes should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Form 10-K as filed with the SEC on February 17, 2006.

2. Computation of Earnings per Share

The computation of basic earnings per share (“EPS”) is based on the weighted average number of common shares outstanding during each period. The computation of diluted EPS is based on the weighted average number of common shares outstanding during the period plus, when their effect is dilutive, incremental shares consisting of shares subject to stock options, unvested restricted stock, and shares issued upon conversion of convertible debt.

Emerging Issues Task Force Issue No. 04-08, “The Effect of Contingently Convertible Instruments on Diluted Earnings per Share” (“EITF 04-08”), requires companies to account for contingently convertible debt using the “if converted” method set forth in Statement of Financial Accounting Standard (“SFAS”) No. 128, “Earnings per Share,” for calculating diluted EPS. Under the “if converted” method, the after-tax effect of interest expense related to the convertible securities is added back to net income and convertible debt is assumed to have been converted to equity at the beginning of the period and is added to outstanding common shares, unless the inclusion of such shares is anti-dilutive. For the second quarter of 2006, the “if converted” method, based on interest expense, net of tax, of $624,000 for the second quarter of 2006 and $1.3 million for the first six months of 2006 and 5,305,040 shares from the assumed conversion of convertible debt, yields the same diluted earnings per share results as calculated below.

The following is a reconciliation of the computations of basic and diluted EPS information for the periods presented (in thousands, except per share data):

	Three Months Ended June 30,				Six Months Ended June 30,
	2006		2005		2006		2005
BASIC AND DILUTED:
Net income	$	6,414	$	4,979	$	13,252	$	9,277
Weighted average shares outstanding (basic)		42,370		41,988		42,140		41,852
Effect of dilutive securities:
Unvested common shares outstanding		586		535		554		531
Stock options		2,438		2,293		2,854		2,000
Adjusted weighted average shares for diluted EPS		45,394		44,816		45,548		44,383
Basic earnings per share	$	0.15	$	0.12	$	0.31	$	0.22
Diluted earnings per share	$	0.14	$	0.11	$	0.29	$	0.21

3. Stock-Based Compensation

In December 2004, the Financial Accounting Standards Board (“FASB”) issued SFAS No. 123R, “Share-Based Payment.” This statement requires that the cost resulting from all share-based payment transactions be recognized in the financial statements. This statement establishes fair value as the measurement objective in accounting for share-based payment arrangements and requires all entities to apply a fair-value based measurement method in accounting for share-based payment transactions with employees except for equity instruments held by employee share ownership plans.

4

Prior to the January 1, 2006 adoption of SFAS No. 123R, the Company accounted for stock-based compensation using the intrinsic value method prescribed in Accounting Principles Board Opinion No. 25 (“APB 25”), “Accounting for Stock Issued to Employees,” and related interpretations. Accordingly, no compensation expense had been recognized for stock options since all options granted had an exercise price equal to the market price on the date of grant. As permitted by SFAS No. 123, “Accounting for Stock-Based Compensation,” stock-based compensation was included as a pro forma disclosure in the notes to the consolidated financial statements.

Effective January 1, 2006, the Company adopted the fair value recognition provisions of SFAS No. 123R, using the modified prospective method. Under this method, the provisions of SFAS No. 123R apply to all awards granted or modified after the date of adoption and all previously granted awards not yet vested as of the date of adoption. Prior periods have not been restated.

The following table is a summary of the amount of stock-based compensation expense recognized in the consolidated statement of operations for the three and six months ended June 30, 2006 (in thousands).

	Three Months Ended June 30, 2006		Six Months Ended June 30, 2006
Cost of revenue – recurring	$	205	$	357
Cost of revenue – non-recurring		236		439
Research and development		213		399
Selling, general and administrative		1,362		2,349
Total	$	2,016		3,544

The Company has the following stock-based compensation plans: (i) the 1998 Long-Term Incentive Plan, which is an amendment and restatement of the 1998 Stock Option Plan, permits the Company to grant other types of awards in addition to stock options, (ii) the RIMS Stock Option Plan, a plan the Company assumed through the acquisition of Resource Information Management Systems, Inc. in late 2000, and (iii) the Employee Stock Purchase Plan, which allows full-time employees to purchase shares of the Company’s common stock at a discount to fair market value.

SFAS No. 123R requires disclosure of pro forma information for periods prior to the adoption. The following table illustrates the effect on net income and net income per share if the Company had applied the fair value recognition provisions of SFAS No. 123R to stock-based employee compensation (in thousands, except per share data):

	Three Months Ended June 30, 2005			Six Months Ended June 30, 2005
Net income as reported	$	4,979		$	9,277
Add: stock-based employee compensation expense included in reported net income, net of related tax effects		—			—
Deduct: stock-based employee compensation expense determined under fair value based method for all awards, net of related tax effects		(1,291	)		(3,148	)
Pro forma net income	$	3,688		$	6,129
Net income per share
Basic, as reported	$	0.12		$	0.22
Diluted, as reported	$	0.11		$	0.21
Basic, pro forma	$	0.09		$	0.15
Diluted, pro forma	$	0.08		$	0.14

5

The fair value of option grants was estimated using the Black-Scholes pricing model. The Company evaluates the assumptions used to value stock awards on a quarterly basis. No options were granted in the second quarter of 2006. The following weighted average assumptions were used for the periods presented:

	Three Months Ended June 30,			Six Months Ended June 30,
	2005			2006			2005
Expected volatility		55	%		45	%		55	%
Risk-free interest rate		3.70	%		4.75	%		3.70	%
Expected life		4 years			6.25 years			4 years
Forfeiture rate		—			6.0	%		—
Expected dividends		—			—			—
Weighted average fair value	$	5.28		$	8.61		$	3.93

The following is a summary of stock option activity for the six months ended June 30, 2006 (in thousands, except per share data):

	Number of Shares		Weighted Average Exercise Price		Weighted Average Remaining Contractual Life	Aggregate Intrinsic Value
Options Outstanding at December 31, 2005	8,247		$	9.44
Granted	647			16.91
Exercised	(697	)		8.77
Cancelled	(110	)		9.49
Options Outstanding at June 30, 2006	8,087		$	10.10	6.74	$	43,733
Exercisable at June 30, 2006	4,304		$	10.34	5.52	$	22,319

Expected volatility is based on implied volatility from traded options on the Company’s stock and historical volatility of the Company’s stock. The risk-free interest rate is the U.S. Treasury rate for the week of the grant having a term equal to the expected life of the option. The expected life of options granted represents the period of time that options granted are expected to be outstanding. The Company has determined that historical experience is not a good predictor of future exercise patterns and thus has applied the “simplified” method outlined in Staff Accounting Bulletin No. 107, “Share-Based Payment,” to calculate expected life. The forfeiture rate is the estimated percentage of options granted that are expected to be forfeited or cancelled before becoming fully vested and is based on historical experience. The Company has not made any dividend payments nor does it have plans to pay dividends in the foreseeable future.

The total intrinsic value of options exercised during the six months ended June 30, 2006 was $5.9 million. As of June 30, 2006, $12.3 million of total unrecognized compensation cost related to stock options is expected to be recognized over a weighted average period of 1.56 years.

The following table summarizes nonvested restricted stock awards as of June 30, 2006 and changes during the six months ended June 30, 2006 (in thousands, except per share data):

	Number of Shares		Weighted-Average Grant-Date Fair Value
Nonvested at December 31, 2005	479		$	7.64
Granted	182			16.98
Vested	(113	)		6.81
Forfeited	(4	)		16.81
Nonvested at June 30, 2006	544		$	15.76

As of June 30, 2006, there was $5.0 million of total unrecognized compensation cost related to nonvested restricted stock awards, which will be amortized over the weighted-average remaining service period of 2.51 years.

6

4. Supplemental Cash Flow Disclosures

The following table is a summary of supplemental cash flow disclosures as follows (in thousands):

	Six Months Ended June 30,
	2006		2005
SUPPLEMENTAL DISCLOSURES FOR CASH FLOW INFORMATION
Cash paid for interest	$	1,613	$	595
Cash paid for income taxes		502		542
NON-CASH INVESTING AND FINANCING ACTIVITIES
Assets acquired through capital lease		—		147
Goodwill adjustment		2,675		—

5. Accrued Liabilities

Accrued liabilities consist of the following (in thousands):

	June 30, 2006		December 31, 2005
Accrued payroll and benefits	$	17,091	$	20,619
Accrued professional and litigation fees and settlements		1,275		1,590
Accrued acquisition costs		93		25,611
Accrued outside services		563		959
Accrued income and other taxes		1,472		1,191
Other		7,097		6,987
	$	27,591	$	56,957

Effective January 1, 2006, the Company became self-insured for certain losses related to employee health and dental benefits. The Company records a liability based on an estimate of claims incurred but not recorded determined based on actuarial analysis of historical claims experience and historical industry data. The Company maintains individual and aggregate stop-loss coverages with a third party insurer to limit its total exposure for these programs.

6. Debt

In January 2006, the Company entered into an amendment to its Credit Agreement established December 21, 2004. The amendment increased the amount of the revolving credit facility from $50 million to $100 million, subject to certain fixed percentages of our recurring revenues, and extended the expiration date of the Credit Agreement to January 5, 2010. Principal outstanding under the facility bears interest at a per annum rate equal to either (i) the LIBOR rate plus an adjustable applicable margin of between 1.75% and 2.25% or (ii) the lending institution’s prime rate plus an adjustable applicable margin of between 0.0% and 0.5%, at the Company’s election, subject to specified restrictions. The unused portions of the facility are subject to unused facility fees. In the event the Company terminates the Credit Agreement prior to its expiration, the Company will be required to pay the lending institution a termination fee equal to 2% of the maximum credit amount if the termination is prior to the second anniversary of the Credit Agreement or 1% of the maximum credit amount if the Credit Agreement is terminated thereafter, up to 90 days prior to the expiration of the Credit Agreement, subject to specified exceptions. Management expects to use the proceeds for general working capital purposes and has granted the lending institution a security interest in all of the Company’s assets. The Credit Agreement contains customary affirmative and negative covenants for credit facilities of this type, including limitations with respect to indebtedness, liens, investments, distributions, mergers and acquisitions, dispositions of assets and transactions with our affiliates. The Credit Agreement also includes financial covenants including minimum EBITDA, minimum liquidity, minimum recurring revenue and maximum capital expenditures. As of June 30, 2006, the Company was in compliance with all applicable covenants and other restrictions under the Credit Agreement. As of June 30, 2006, the Company had outstanding borrowings on the revolving line of credit of $4.0 million.

In October 2005, the Company issued $100 million aggregate principal amount of 2.75% Convertible Senior Notes due 2025 (the “Notes”). The Notes are convertible into shares of the Company’s common stock at an initial conversion price of

7

$18.85 per share, or 53.0504 shares for each $1,000 principal amount of Notes, subject to certain adjustments. The Notes bear interest at a rate of 2.75%, which is payable in cash semi-annually.

Debt consists of the following for the periods presented (in thousands):

	Notes Payable						Line of Credit
	June 30, 2006			December 31, 2005			June 30, 2006		December 31, 2005
Long-term convertible debt, due in 2025, interest at 2.75% fixed rate payable semi-annually in arrears	$	100,000		$	100,000		$	—	$	—
Revolving credit facility of $100.0 million, interest at the lending institution’s prime rate (8.25% at June 30, 2006), payable monthly in arrears		—			—			4,000		—
Other		754			120			—		—
Total debt		100,754			100,120			4,000		—
Less: Current portion		(754	)		(120	)		—		—
	$	100,000		$	100,000		$	4,000	$	—

As of June 30, 2006, the Company had outstanding four unused standby letters of credit in the aggregate amount of $1.0 million, which serve as security deposits for certain capital and operating leases and insurance policies. The Company is required to maintain a cash balance equal to the outstanding letters of credit, which is classified as restricted cash on the balance sheet.

7. Loss on Contracts

During the fourth quarter of 2003, the Company decided to wind-down its outsourcing services to physician group customers. In the second quarter of 2005, the Company executed termination agreements with its two remaining physician group customers, allowing the Company to reverse the remaining balance in its loss on contracts accrual of $2.9 million.

8. Litigation

In September 2004, McKesson Information Solutions LLC (“McKesson”) filed a lawsuit against the Company in the United States District Court for the District of Delaware. In its complaint, McKesson alleged that the Company made, used, offered for sale, and/or sold a clinical editing software system that infringes McKesson’s United States Patent No. 5,253,164, entitled “System And Method For Detecting Fraudulent Medical Claims Via Examination Of Services Codes.” McKesson seeks injunctive relief and substantial monetary damages, including treble damages for willful infringement. On April 4, 2006, in response to the Company’s motion for summary judgment, the court ruled, as a matter of law, that the Company’s software products do not infringe 12 of the 15 claims of McKesson’s patent that were involved in this dispute, leaving claims 1, 2 and 16.

On April 17, 2006, a jury trial commenced on the first phase of this case to determine the issue of infringement of the remaining three claims. On April 26, 2006, the jury found that the Company’s Facets^®, QicLink^™ and ClaimFacts^® software products infringe claims 1 and 2, but not claim 16 of the patent. On May 4, 2006, the court decided that it would not entertain post-trial motions involving infringement until the second phase of the trial has been completed. The court also scheduled the second phase of the trial to commence on October 3, 2006 on the issues of our validity, estoppel and laches defenses and on the issue of McKesson’s damages, if any.

Since the first phase of the trial, the Company has been involved in discussions with McKesson to settle this lawsuit. The parties have not yet resolved a number of important issues nor agreed upon a final definitive settlement agreement. Accordingly, there can be no assurance that a settlement will be achieved. The parties, however, have discussed certain terms of a potential settlement, whereby the Company would pay McKesson a royalty fee to allow its existing customers to continue to use its clinical editing software without interruption. The potential settlement also would clarify the manner in which the Company’s clinical editing software may or may not be used in future sales. In the event the parties enter into a settlement agreement prior to the second phase of the trial requiring the Company to pay McKesson a royalty fee, payment of this fee in the amount currently being discussed would not be expected to materially affect the Company’s overall financial position or ability to fund future operations. Such amount, however, would have a material adverse impact on the Company’s 2006 results of operations and cash flows.

As of the filing of this quarterly report on Form 10-Q, the Company did not accrue any liability related to this lawsuit as the Company did not believe at such time that its liability to McKesson is considered probable and can be reasonably estimated. The Company’s attorney fees and other defense costs related to this matter are being expensed as incurred. If the Company does not prevail on certain of its defenses at the second phase of the trial and the injunction sought by McKesson is granted by the Court, the Company could be liable for substantial monetary damages and be precluded from offering all or a portion of its clinical editing software to its customers. In addition, pursuant to contractual obligations with many of its Facts^™, Facets^® and QicLink^™ customers, the Company may be required, at its cost, to replace all or a portion of its clinical editing software with a non-infringing alternative solution. An adverse decision in this litigation could have a material adverse effect on the Company’s results of operations, financial position and/or cash flows.

8

In addition to the matter described above, the Company is involved in litigation from time to time relating to claims arising out of its operations in the normal course of business. Except as discussed above, as of the filing date of this quarterly report on Form 10-Q, the Company was not a party to any other legal proceedings, the adverse outcome of which, in management’s opinion, individually or in the aggregate, would have a material adverse effect on its results of operations, financial position and/or cash flows.

9. Acquisition

On December 22, 2005, the Company acquired all of the issued and outstanding shares of CareKey, Inc. (“CareKey”) for cash. The acquisition was accounted for using the purchase method of accounting. As of December 31, 2005, the excess of the purchase price over the preliminary fair market value of the assets purchased and liabilities assumed was $47.7 million and was allocated to goodwill.

In April 2006, the Company received an estimate from its independent valuation firm of the fair market value of certain intangible assets acquired from CareKey. Based on this estimate, the Company booked adjustments to goodwill of $17.4 million, which primarily included a $15.0 million contingent payment, and allocated $31.0 million to identifiable intangible assets in the financial statements for the first quarter of 2006.

Subsequently, the Company received a preliminary valuation report from its independent valuation firm in June 2006 that reduced the value of identifiable intangible assets to $29.3 million. The $29.3 million allocated to identifiable intangible assets includes customer relationships and maintenance agreements of $7.0 million to be amortized over a ten-year life, existing software of $14.2 million to be amortized over a five-year life, and core technology of $8.1 million to be amortized over a ten-year life. As a result, the Company has recorded approximately $2.2 million of amortization expense for the six months ended June 30, 2006. Once the Company completes its final determination of the fair market value of the assets and liabilities assumed, further adjustments and allocations between goodwill and identifiable intangible assets may be recorded.

CareKey stockholders and optionholders are entitled to receive three contingent consideration payments of $8.3 million each (up to $25.0 million), upon the achievement of certain revenue milestones during the period beginning upon acquisition and ending December 31, 2008. In addition, further consideration payable in cash or stock at TriZetto’s election, may be paid to former CareKey stockholders and optionholders if, prior to December 31, 2008, the acquired CareKey products generate revenues in excess of certain revenue milestones and/or if a negotiated multiple of software maintenance revenues of acquired CareKey products during the fiscal year ended December 31, 2009 exceeds total purchase consideration made to those former CareKey stockholders and optionholders.

9

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

We offer a broad portfolio of proprietary information technology products and services targeted to the payer industry, which is comprised of health insurance plans and third party benefits administrators. We offer: enterprise administration software, including Facets Extended Enterprise™ and QicLink Extended Enterprise™, and CareAdvance™ enterprise care management software; specialized component software, including our NetworX™ products for provider network management, HealthWeb^®, a suite of web interface tools, and CDH Account Management and Workflow add-on modules for Facets^®; software hosting services and business process outsourcing services, which provide variable cost alternatives to licensing software; and strategic, installation, and optimization consulting services. We provide products and services to 290 unique customers in the health plan and benefits administrator markets, which we refer to as payers. In the second quarter of 2006, these markets represented 90% and 10% of our total revenue, respectively.

We measure financial performance by monitoring recurring revenue and non-recurring revenue, bookings and backlog, gross profit, and net income. Total revenue for the second quarter of 2006 was $87.7 million compared to $72.5 million for the same period in 2005. Recurring revenue for the second quarter of 2006 was $43.7 million compared to $40.1 million for the same period in 2005. Non-recurring revenue for the second quarter of 2006 was $44.0 million compared to $32.4 million for the same period in 2005. Bookings for the second quarter of 2006 were $78.6 million compared to $85.3 million for the same period in 2005. Backlog at June 30, 2006 was $717.5 million compared to $638.9 million at June 30, 2005. Gross profit was $42.5 million for the second quarter in 2006 compared to $33.4 million for the same period in 2005. Net income in the second quarter of 2006 was $6.4 million compared to $5.0 million for the same period in 2005. These financial comparisons are further explained in the section below, “Results of Operations.”

We generate recurring revenue from several sources, including the provision of outsourcing services, such as software hosting and business process outsourcing services, and the sale of maintenance and support for our proprietary and certain of our non-proprietary software products. We generate non-recurring revenue from the licensing of our software and from consulting fees for implementation, installation, configuration, business process engineering, data conversion, testing and training related to the use of our proprietary, and third-party licensed products. Cost of revenue includes costs related to the products and services we provide to our customers and costs associated with the operation and maintenance of our customer connectivity centers. These costs include salaries and related expenses for consulting personnel, customer connectivity centers’ personnel, customer support personnel, application software license fees, amortization of capitalized software development costs, telecommunications costs, facility costs, and maintenance costs. Research and development (“R&D”) expenses are salaries and related expenses associated with the development of software applications prior to establishing technological feasibility. Such expenses include compensation paid to software engineering personnel and other administrative, infrastructure and facility expenses and fees to outside contractors and consultants. Selling, general and administrative expenses consist primarily of salaries and related expenses for sales, sales commissions, account management, marketing, administrative, finance, legal, human resources and executive personnel, and fees for certain professional services.

As part of our growth strategy, we intend to increase revenue per customer by continuing to introduce new complementary products and services, including new cost and quality of care products and services, to our established enterprise software and hosting and business process outsourcing services. Some of these service offerings, including hosting, business process outsourcing, and consulting have a higher cost of revenue, resulting in lower gross profit margins. Therefore, to the extent that our revenue increases through the sale of these lower margin product and service offerings, our total gross profit margin may decrease.

We are continuing to target larger health plan customers. This has given us the opportunity to sell additional services such as software hosting, business intelligence, and business process outsourcing services. As the technology requirements of our customers become more sophisticated, our service offerings have become more complex. This has lengthened our sales cycles and made it more difficult for us to predict the timing of our software and services sales.

In late 2003, a management decision was made to exit certain non-strategic and less profitable product offerings and business lines. This decision included winding down services related to our physician group customers, as well as the planned elimination of our hosting and business process outsourcing services for two competing third-party software platforms. Early in the second quarter of 2005, we executed termination agreements with the last two of our remaining physician group customers. We continued to provide outsourced business services through May 2005 when the transition services were completed.

10

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

The discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amount of assets and liabilities, revenues and expenses, and related disclosures of contingent assets and liabilities at the date of our financial statements. Those estimates are based on our experience, terms of existing contracts, observance of trends in the industry, information provided by our customers and information available from other outside sources, which are believed to be reasonable under the circumstances. Actual results may differ from these estimates under different assumptions or conditions.

The following critical accounting policies affect the more significant judgments and estimates used in the preparation of our consolidated financial statements, and may potentially result in materially different results under different assumptions and conditions. We have identified the following as critical accounting policies to our company:

• Revenue recognition;

• Up-front payments to customers;

• Sales returns and allowance for doubtful accounts;

• Capitalization of software development costs;

• Goodwill and other intangible assets;

• Litigation accruals;

• Self-insurance;

• Bonus accruals;

• Income taxes; and

• Stock-based compensation.

This is not a comprehensive list of all of our accounting policies. For a detailed discussion on the application of these and other accounting policies, see Note 2 of Notes to Consolidated Financial Statements included in our Form 10-K as filed with the SEC on February 17, 2006.

Revenue Recognition.We recognize revenue when persuasive evidence of an arrangement exists, the product or service has been delivered, fees are fixed or determinable, collection is reasonably assured and all other significant obligations have been fulfilled. Our revenue is classified into two categories: recurring and non-recurring. For the six months ended June 30, 2006, approximately 51% of our total revenue was recurring and 49% was non-recurring.

We follow the provisions of the Securities and Exchange Commission Staff Accounting Bulletin No. 104, “Revenue Recognition,” AICPA Statement of Position (“SOP”) 97-2, “Software Revenue Recognition,” as amended, EITF 00-3, “Application of AICPA Statement of Position 97-2 to Arrangements That Include the Right to Use Software Stored on Another Entity’s Hardware,” and EITF Issue 00-21, “Revenue Arrangements with Multiple Deliverables.”

We generate recurring revenue from several sources, including the provision of outsourcing services, such as software hosting and other business services, and the sale of maintenance and support for our proprietary software products. Recurring services revenue is typically billed and recognized monthly over the contract term, typically three to seven years. Many of our outsourcing agreements require us to maintain a certain level of operating performance. We record revenue net of estimated penalties resulting from any failure to maintain the level of operating performance. These penalties have not been significant in the past. Recurring software maintenance revenue is typically based on one-year renewable contracts. Software maintenance and support revenues are recognized ratably over the contract period. Payment for software maintenance received in advance is recorded on the balance sheet as deferred revenue. Certain royalty costs paid to third-party software vendors associated with software maintenance are amortized over the software maintenance period.

11

We generate non-recurring revenue from the licensing of our software. Under SOP 97-2, software license revenue is recognized upon the execution of a license agreement, upon delivery of the software, when fees are fixed or determinable, when collectibility is probable and when all other significant obligations have been fulfilled. For software license agreements in which customer acceptance is a significant condition of earning the license fees, revenue is not recognized until acceptance occurs. For software license agreements that require significant customizations or modifications of the software, revenue is recognized as the customization services are performed. For multiple element arrangements, such as software license, consulting services, outsourcing services and maintenance, and where vendor-specific objective evidence (“VSOE”) of fair value exists for all undelivered elements, we account for the delivered elements in accordance with the “residual method.” Under the residual method, the arrangement fee is recognized as follows: (1) the total fair value of the undelivered elements, as indicated by VSOE, is deferred and subsequently recognized in accordance with the relevant sections of SOP 97-2 and (2) the difference between the total arrangement fee and the amount deferred for the undelivered elements is recognized as revenue related to the delivered elements. For arrangements in which VSOE does not exist for each undelivered element, including specified upgrades, revenue for the delivered element is deferred and not recognized until VSOE is available for the undelivered element or delivery of each element has occurred. When multiple products are sold within a discounted arrangement, a proportionate amount of the discount is applied to each product based on each product’s fair value or relative list price.

We also generate non-recurring revenue from consulting fees for implementation, installation, configuration, business process engineering, data conversion, testing and training related to the use of our proprietary and third party licensed products. In certain instances, we also generate non-recurring revenue from customization services of our proprietary licensed products. We recognize revenue for these services as they are performed, if contracted on a time and materials basis, or using the percentage of completion method, if contracted on a fixed fee basis and when we can adequately estimate the cost of the consulting project. Percentage of completion is measured based on cost incurred to date compared to total estimated cost at completion. When we cannot reasonably estimate the cost to complete, we recognize revenue using the completed contract method, upon completion of all contractual obligations. We also generate non-recurring revenue from set-up fees, which are services, hardware, and software associated with preparing our customer connectivity center or a customer’s data center in order to ready a specific customer for software hosting services. The set-up fees are usually separate and distinct from the hosting fees, and performance of the set-up services represents the culmination of the earnings process. We recognize revenue for these services as they are performed using the percentage of completion basis and when we can reasonably estimate the cost of the set-up project. We also generate non-recurring revenue from certain one-time charges, including certain contractual fees such as termination fees and change of control fees, and we recognize the revenue for these fees once the termination or change of control is guaranteed, there are no remaining substantive performance obligations and collection is reasonably assured. Other non-recurring revenue is also generated from fees related to our product related conference.

Up-front Payments to Customers.We may pay certain up-front amounts to our customers in connection with the establishment of our hosting and outsourcing services contracts. Under EITF 01-9, “Accounting for Consideration Given by a Vendor to a Customer (Including a Reseller of the Vendor’s Products),” these payments are capitalized and amortized over the life of the contract as a reduction to revenue, provided that such amounts are recoverable from future revenue under the contract. If an up-front payment is not recoverable from future revenue, or it cannot be offset by contract cancellation penalties paid by the customer, the amount will be expensed in the period it is deemed unrecoverable. Unamortized up-front fees were $6.9 million and $4.4 million as of June 30, 2006 and 2005, respectively.

Sales Returns and Allowance for Doubtful Accounts.We maintain an allowance for sales returns to reserve for estimated discounts, pricing adjustments, and other sales allowances. The reserve is charged to revenue in amounts sufficient to maintain the allowance at a level we believe is adequate based on historical experience and current trends. We also maintain an allowance for doubtful accounts to reflect estimated losses resulting from the inability of customers to make required payments. We base this allowance on estimates after consideration of factors such as the composition of the accounts receivable aging and bad debt history and our evaluation of the financial condition of the customers. If the financial condition of customers were to deteriorate, resulting in an impairment of their ability to make payments, additional sales allowances and bad debt expense may be required. We typically do not require collateral. Historically, our estimates for sales returns and doubtful account reserves have been adequate to cover accounts receivable exposures. We continually monitor these reserves and make adjustments to these provisions when we believe actual credits or other allowances may differ from established reserves.

Capitalization of Software Development Costs.The capitalization of software costs includes developed technology acquired in acquisitions and cost incurred by us in developing our products that qualify for capitalization. We account for our software development costs, other than costs for internal-use software, in accordance with FASB Statement No. 86, “Accounting for Costs of Computer Software to be Sold, Leased or Otherwise Marketed.” We capitalize costs associated

12

with product development, coding and testing subsequent to establishing technological feasibility of the product. Technological feasibility is established after completion of a detailed program design or working model. Capitalization of computer software costs ceases upon a product’s general availability release. Capitalized software development costs are amortized over the estimated useful life of the software product starting from the date of general availability.

On a quarterly basis, we monitor the expected net realizable value of the capitalized software for factors that would indicate impairment, such as a decline in the demand, the introduction of new technology, or the loss of a significant customer. As of June 30, 2006, our evaluation determined that the carrying amount of these assets was not impaired.

Goodwill and Other Intangible Assets. Acquisitions are accounted for using the purchase method of accounting. The purchase price is allocated to the tangible and intangible assets acquired and the liabilities assumed on the basis of their estimated fair market values on the acquisition date. The excess of the purchase price over the estimated fair market value of the assets purchased and liabilities assumed is allocated to goodwill and other intangible assets.

Under FASB Statement No. 142, “Goodwill and Other Intangible Assets,” goodwill and intangible assets deemed to have indefinite lives are subject to annual (or more often if indicators of impairment exist) impairment tests using a two-step process. The first step looks for indicators of impairment. If indicators of impairment are revealed in the first step, then the second step is conducted to measure the amount of the impairment, if any. We performed our annual impairment test on March 31, 2006, and this test did not reveal indications of impairment.

Litigation Accruals. Pending unsettled lawsuits involve complex questions of fact and law and may require expenditure of significant funds. From time to time, we may enter into confidential discussions regarding the potential settlement of such lawsuits; however, there can be no assurance that any such discussions will occur or will result in a settlement. Moreover, the settlement of any pending litigation could require us to incur settlement payments and costs. In the period in which a new legal case arises, an expense will be accrued if our liability to the other party is probable and can be reasonably estimated. On a quarterly basis, we review and analyze the adequacy of our accruals for each individual case for all pending litigations. Adjustments are recorded as needed to ensure appropriate levels of reserve. Our attorney fees and other defense costs related to litigation are expensed as incurred.

Self-Insurance.Effective January 1, 2006, we became self-insured for certain losses related to employee health and dental benefits. We record a liability based on an estimate of claims incurred but not recorded determined based on actuarial analysis of historical claims experience and historical industry data. We maintain individual and aggregate stop-loss coverages with a third party insurer to limit our total exposure for these programs. Our self-insurance liability contains uncertainties because the calculation requires management to make assumptions and apply judgment to estimate the ultimate cost to settle reported claims and claims incurred but not reported as of the balance sheet date. We do not believe that there is a reasonable likelihood that there will be a material change in the future assumptions or estimates we use to calculate our self-insurance liability. However, if actual results are not consistent with our assumptions and estimates, we may be exposed to losses or gains that could be material.

Bonus Accruals.Our corporate bonus model is designed to project the level of funding required under the corporate bonus program as approved by the Compensation Committee of the Board of Directors. A significant portion of the corporate bonus program is based on the Company meeting certain financial objectives, such as revenue, earnings per share, and the level of capital spending. The expense related to the corporate bonus program is accrued in the year of performance and paid in the first quarter following the fiscal year end. The corporate bonus model is analyzed and adjusted on a quarterly basis as necessary based on achievement of targets.

Income Taxes.We account for income taxes under FASB Statement No. 109, “Accounting for Income Taxes.” This statement requires the recognition of deferred tax assets and liabilities for the future consequences of events that have been recognized in our financial statements or tax returns. The measurement of the deferred items is based on enacted tax laws. In the event the future consequences of differences between financial reporting bases and the tax bases of our assets and liabilities result in a deferred tax asset, FASB Statement No. 109 requires an evaluation of the probability of being able to realize the future benefits indicated by such asset. A valuation allowance related to a deferred tax asset is recorded when it is more likely than not that some portion or all of the deferred tax asset will be not realized. During 2006, we estimate our valuation allowance will decrease by $11.5 million as a result of preliminary purchase accounting and related deferred tax accounting adjustments associated with the acquisition of CareKey, Inc. (“CareKey”). In addition, based upon projected current year operating income, we anticipate reducing our valuation allowance by approximately $10.0 million as a result of the utilization of net operating loss carryovers. Of our remaining valuation allowance, approximately $1.1 million relates to net operating loss carryovers acquired in prior business combinations and $5.2 million relates to excess tax benefits from

13

prior stock option exercises. Upon realization of these benefits, goodwill will be reduced and equity will be increased by $1.1 million and $5.2 million, respectively.

Stock-Based Compensation. Effective January 1, 2006, we adopted the fair value recognition provisions of FASB Statement No. 123R, “Share-Based Payment,” using the modified prospective transition method, and therefore have not restated prior periods’ results. Under this method, we recognize compensation expense for all share-based payments granted after January 1, 2006 and for all share-based payments granted prior to, but not yet vested as of, January 1, 2006. Under the fair value recognition provisions of FASB Statement No. 123R, stock-based compensation cost is estimated at the grant date based on the award’s fair-value and is recognized as expense ratably over the requisite service period. We use the Black-Scholes option-pricing model to calculate fair value which requires the input of highly subjective assumptions. These assumptions include estimating the length of time employees will retain their vested stock options before exercising them (“expected term”), the estimated volatility of our common stock price over the expected term and the number of options that will ultimately not complete their vesting requirements (“forfeitures”). The assumptions used in calculating the fair value of share-based payment awards represent management’s best estimates, but these estimates involve inherent uncertainties and the application of management judgment. As a result, if factors change and we use different assumptions, our stock-based compensation could be materially different in the future. In addition, if our actual forfeiture rate is materially different from our estimate, stock-based compensation expense could be significantly different from what we have recorded in the current period.

REVENUE INFORMATION

Revenue by customer type and revenue mix for the three and six months ended June 30, 2006 and 2005, respectively, is as follows (in thousands):

	Three Months Ended June 30,								Six Months Ended June 30,
	2006				2005				2006				2005
Revenue by customer type:
Health plans	$	78,673	90	%	$	63,429	88	%	$	155,067	90	%	$	125,691	87	%
Benefits administrator		9,037	10	%		9,013	12	%		17,961	10	%		18,493	13	%
Provider		—	0	%		66	0	%		—	0	%		142	0	%
Total revenue	$	87,710	100	%	$	72,508	100	%	$	173,028	100	%	$	144,326	100	%
Revenue mix:
Recurring revenue
Outsourced business services	$	21,426	49	%	$	20,383	51	%	$	43,988	50	%	$	39,794	50	%
Software maintenance		22,251	51	%		19,733	49	%		43,399	50	%		39,345	50	%
Recurring revenue total		43,677	100	%		40,116	100	%		87,387	100	%		79,139	100	%
Non-recurring revenue
Software license fees		17,917	41	%		11,026	34	%		37,463	44	%		27,250	41	%
Consulting services		25,333	57	%		20,827	64	%		47,395	55	%		37,398	58	%
Other non-recurring revenue		783	2	%		539	2	%		783	1	%		539	1 %
Non-recurring revenue total		44,033	100	%		32,392	100	%		85,641	100	%		65,187	100	%
Total revenue	$	87,710			$	72,508			$	173,028			$	144,326

Our total backlog is defined as the revenue we expect to generate in future periods from existing customer contracts. Our 12-month backlog is defined as the revenue we expect to generate from existing customer contracts over the next 12 months. Most of the revenue in our backlog is derived from multi-year recurring revenue contracts (including software hosting, business process outsourcing, IT outsourcing, and software maintenance with periods up to seven years). We classify revenue from software license and consulting contracts as non-recurring. Consulting revenue is included in the backlog when the revenue from such consulting contract will be recognized over a period exceeding 12 months.

Backlog can change due to a number of factors, including unforeseen changes in implementation schedules, contract cancellations (subject to penalties paid by the customer), or customer financial difficulties. In such event, unless we enter into new customer agreements that generate enough revenue to replace or exceed the revenue we expect to generate from our backlog in any given quarter, our backlog will decline. Our backlog at any date may not indicate demand for our products and services and may not reflect actual revenue for any period in the future.

14

Our 12-month and total backlog data are as follows (in thousands):

	6/30/06		3/31/06		12/31/05		9/30/05		6/30/05
12-month backlog:
Recurring revenue	$	171,300	$	169,500	$	164,600	$	157,800	$	153,600
Non-recurring revenue		14,800		17,800		20,500		36,700		21,200
Total	$	186,100	$	187,300	$	185,100	$	194,500	$	174,800
Total backlog:
Recurring revenue	$	694,600	$	676,000	$	668,700	$	612,100	$	615,000
Non-recurring revenue		22,900		28,600		34,700		51,000		23,900
Total	$	717,500	$	704,600	$	703,400	$	663,100	$	638,900

Total quarterly bookings equal the estimated total dollar value of the contracts signed in the quarter. Bookings can vary substantially from quarter to quarter, based on a number of factors, including the number and type of prospects in our pipeline, the length of time it takes a prospect to reach a decision and sign the contract, and the effectiveness of our sales force. Included in quarterly bookings are maintenance revenue and hosting and other services revenue up to seven years. Bookings for each of the quarters are as follows (in thousands):

	6/30/06		3/31/06		12/31/05		9/30/05		6/30/05
Quarterly Bookings	$	78,600	$	87,400	$	83,100	$	75,100	$	85,300

RESULTS OF OPERATIONS

QUARTER ENDED JUNE 30, 2006 COMPARED TO THE QUARTER ENDED JUNE 30, 2005

Revenue. Total revenue increased $15.2 million, or 21%, to $87.7 million in the second quarter of 2006 from $72.5 million for the same period in 2005. Of this increase, $3.6 million related to recurring revenue and $11.6 million related to non-recurring revenue.

Recurring Revenue. Recurring revenue increased $3.6 million, or 9%, to $43.7 million in the second quarter of 2006 from $40.1 million for the same period in 2005. This increase was the result of a $1.0 million increase in outsourced business services and an increase of $2.6 million in software maintenance revenue. The overall increase in outsourced business services revenue was primarily due to increased membership from existing Facets^® hosted customers. The increase of $2.6 million in software maintenance revenue was attributable primarily to new agreements for certain Facets^®, NetworX™, HealthWeb^® and CareAdvance™ customers and annual rate increases from our existing customers.

Non-recurring Revenue.Non-recurring revenue increased $11.6 million, or 36%, to $44.0 million in the second quarter of 2006 from $32.4 million for the same period in 2005. This increase was the result of a $4.5 million increase in consulting services revenue due primarily to new Facets^®, CareAdvance™ and NetworX™ implementations, a $6.9 million increase in software license sales as a result of new sales to our health plan customers, and a $244,000 increase in other non-recurring revenue related to conference revenues and termination fees.

Cost of Revenue. Cost of revenue increased $6.1 million, or 16%, to $45.2 million in the second quarter of 2006 from $39.1 million for the same period in 2005. This increase included a $4.2 million increase in non-recurring cost of revenue and a $2.9 million increase attributable to the reversal of our remaining loss on contracts balance in the second quarter of 2005, partially offset by a $1.0 million decrease in recurring cost of revenue. As a percentage of total revenue, cost of revenue approximated 52% in the second quarter of 2006 and 54% for the same period in 2005.

Recurring Cost of Revenue. The $1.0 million, or 4%, decrease in recurring cost of revenue is primarily attributable to lower utilization of outside consultants of $1.1 million and a $445,000 reduction in royalty expenses, partially offset by higher compensation costs of $642,000 to support the 9% increase in our outsourced services business and software maintenance revenues. The decrease in utilization of outside consultants occurred as a result of an emphasis on using internal resources for product support services. Reduced royalty expenses were attributable to royalties paid in 2005 related to a royalty agreement that ended as a result of the December 2005 acquisition of CareKey. Compensation costs were impacted by the annual merit increases in early 2006, the adoption of SFAS 123R and a reassignment of product and development leaders and other executives to more appropriately align their responsibilities with our market facing strategy.

15

Non-recurring Cost of Revenue. The $4.2 million, or 24%, increase in non-recurring cost of revenue is primarily attributable to higher compensation costs of $4.5 million to support the 36% increase in our consulting and implementation services and software license sales and increased amortization of capitalized software development costs of $434,000, partly offset by a $1.0 million reduction in royalty expenses. Compensation costs were impacted by the annual merit increases in early 2006, the adoption of SFAS 123R and a reassignment of product and development leaders and other executives to more appropriately align their responsibilities with our market facing strategy. New versions of certain of our proprietary software products were released for sale in mid to late 2005 and early 2006, and we began amortizing the capitalized costs. Reduced royalty expenses were attributable to royalties paid in 2005 related to a royalty agreement that ended as a result of the December 2005 acquisition of CareKey.

Loss on Contracts. In the second quarter of 2005, we executed termination agreements with our two remaining physician group customers, allowing us to reverse the remaining balance in our loss on contracts accrual of $2.9 million.

Gross Margin. The overall gross margin increased to 49% in the second quarter of 2006 from 46% for the same period in 2005. The increase in gross margin in the second quarter of 2006 primarily reflected improved pricing, a more profitable mix of products and operating efficiencies.

Research and Development (R&D) Expenses. R&D expenses increased $2.3 million, or 27%, to $10.7 million in the second quarter of 2006 from $8.4 million for the same period in 2005. The increase in R&D expenses reflected the addition of development for cost and quality of care solutions following the December 2005 acquisition of CareKey, as well as continuing investments in our core administration and component software to add new capabilities and functionality for future customer needs. The net increase of $2.3 million was due primarily to higher compensation costs impacted by our annual merit increases in early 2006, increased headcount and the adoption of SFAS 123R. As a percentage of total revenue, R&D expenses approximated 12% in the second quarter of both 2006 and 2005. R&D expenses, as a percentage of total R&D expenditures (which includes capitalized R&D expenses of $2.3 million in the second quarter of 2006 and $2.0 million for the same period in 2005), was 82% in the second quarter of 2006 and 81% for the same period in 2005.

Selling, General and Administrative (SG&A) Expenses. SG&A expenses increased $5.2 million, or 28%, to $24.0 million in the second quarter of 2006 from $18.8 million for the same period in 2005. The overall increase resulted primarily from higher compensation and legal costs. Higher compensation and related costs of $3.1 million were impacted by our annual merit increases in early 2006, increased recruiting fees related to new hires, and our adoption of SFAS 123R, offset in part by a reassignment of product and development leaders and other executives to more appropriately align their responsibilities with our market facing strategy. The increase in legal fees of $2.0 million was attributable to an increase in litigation defense costs in the second quarter of 2006 and a $1.1 million insurance reimbursement related to a legal settlement that occurred in 2005. As a percentage of total revenue, selling, general and administrative expenses approximated 27% in the second quarter of 2006 and 26% for the same period in 2005.

Amortization of Other Intangible Assets. Amortization of other intangible assets increased $211,000, or 25%, to $1.1 million in the second quarter of 2006 from $857,000 for the same period in 2005. The increase was due to amortization of identifiable intangible assets acquired through the CareKey acquisition of $875,000, offset in part by a decrease due to certain intangible assets acquired in previous years which were fully amortized in late 2005. Although the CareKey fair market valuation has not yet been finalized, we have booked an estimate based on the preliminary valuation.

Interest Income. Interest income increased $763,000, or 419%, to $945,000 in the second quarter of 2006 from $182,000 for the same period in 2005. The increase is due primarily to higher cash balances, as well as higher interest earned in our investment accounts.

Interest Expense. Interest expense increased $657,000, or 369%, to $835,000 in the second quarter of 2006 from $178,000 for the same period in 2005. The increase relates primarily to quarterly interest of $688,000 incurred on the $100 million convertible debt issued in the fourth quarter of 2005.

Provision for Income Taxes. Provision for income taxes was $356,000 in the second quarter of 2006 compared to $361,000 for the same period in 2005. The provision for income taxes reflects a benefit from state tax refunds received related to prior years for which income tax benefit was not previously recorded, offset partially by an increase in Federal income taxes. Absent this state tax benefit, our effective tax rate would have been 9.4% for the three-month period ended June 30, 2006, as compared to an effective tax rate of 6.8% for the three-month period ended June 30, 2005. Both rates were lower than the Federal statutory rate primarily due to the decrease in valuation allowance, which occurred as a result of projected utilization of net operating loss (“NOLs”) carryovers. The increase in the effective tax rate for the three-month period ended June 30, 2006 was due to an increase in the provision for Federal taxes.

16

SIX MONTHS ENDED JUNE 30, 2006 COMPARED TO THE SIX MONTHS ENDED JUNE 30, 2005

Revenue. Total revenue increased $28.7 million, or 20%, to $173.0 million in the first six months of 2006 from $144.3 million for the same period in 2005. Of this increase, $8.3 million related to recurring revenue and $20.4 million related to non-recurring revenue.

Recurring Revenue. Recurring revenue increased $8.3 million, or 10%, to $87.4 million in the first six months of 2006 from $79.1 million for the same period in 2005. This increase was the result of a $4.2 million increase in outsourced business services and an increase of $4.0 million in software maintenance revenue. The overall increase in outsourced business services revenue resulted from new Facets^® and CareAdvance™ hosted customers and increased membership from existing Facets^® hosted customers. The increase of $4.0 million in software maintenance revenue was attributable primarily to new agreements for certain Facets^®, NetworX™, HealthWeb^® and CareAdvance™ customers and annual rate increases from our existing customers.

Non-recurring Revenue.Non-recurring revenue increased $20.4 million, or 31%, to $85.6 million in the first six months of 2006 from $65.2 million for the same period in 2005. This increase was the result of a $10.0 million increase in consulting services revenue due primarily to new Facets^®, NetworX™, and CareAdvance™ implementations, a $10.2 million increase in software license sales as a result of new sales to our health plan customers, and a $244,000 increase in other non-recurring revenue related to conference revenues and termination fees.

Cost of Revenue. Cost of revenue increased $11.3 million, or 14%, to $90.0 million in the first six months of 2006 from $78.7 million for the same period in 2005. Of this increase, $1.3 million related to recurring cost of revenue, $7.1 million related to non-recurring cost of revenue and $2.9 million related to the reversal, in the second quarter of 2005, of our remaining loss on contracts accrual. As a percentage of total revenue, cost of revenue approximated 52% in the second quarter of 2006 and 55% for the same period in 2005.

Recurring Cost of Revenue. The $1.3 million, or 3%, increase in recurring cost of revenue is primarily attributable to higher compensation costs of $2.0 million and higher infrastructure and technology costs of $1.7 million to support the 10% increase in our outsourced services business and software maintenance revenues, partly offset by a reduction of $1.7 million attributable to lower utilization of outside consultants and a decrease in royalty expenses of $591,000. Higher compensation costs were impacted by the annual merit increases in early 2006, the adoption of SFAS 123R and a reassignment of product and development leaders and other executives to more appropriately align their responsibilities with our market facing strategy. Higher infrastructure and technology costs were driven by customer and internal upgrades, new operating lease agreements for data center equipment and related maintenance. These costs were offset in part by lower utilization of outside consultants for product support services and a reduction in royalty expenses attributable to royalties paid in 2005 related to a royalty agreement that ended as a result of the December 2005 acquisition of CareKey.

Non-recurring Cost of Revenue. The $7.1 million, or 21%, increase in non-recurring cost of revenue is primarily attributable to higher compensation costs of $6.7 million, increased amortization of capitalized software development costs of $793,000, and our increased investment in infrastructure and technology of $564,000 to support the 31% increase in our consulting and implementation services and software license sales, partly offset by a $649,000 reduction in royalty expenses and a $569,000 reduction in fees from outsourced consultants. Compensation costs were impacted by the annual merit increases in early 2006, the adoption of SFAS 123R and a reassignment of product and development leaders and other executives to more appropriately align their responsibilities with our market facing strategy. New versions of certain of our proprietary software products were released for sale in mid to late 2005 and early 2006, and we began amortizing the capitalized costs to support the related software license sales. We also increased our investment in infrastructure and technology for internal support. The decrease in royalty expenses is attributable to royalties paid in 2005 related to a royalty agreement that ended as a result of the December 2005 acquisition of CareKey. Reduced fees from outsourced consultants were attributable to a higher utilization of internal resources on implementation projects.

Loss on Contracts. In the second quarter of 2005, we executed termination agreements with our two remaining physician group customers, allowing us to reverse the remaining balance in our loss on contracts accrual of $2.9 million.

Gross Margin. The overall gross margin increased to 48% in the first six months of 2006 from 46% for the same period in 2005. The increase in gross margin in the second quarter of 2006 primarily reflected a more profitable mix of products, higher margin new contracts and operating efficiencies.

Research and Development (R&D) Expenses. R&D expenses increased $4.3 million, or 26%, to $21.2 million in the first six months of 2006 from $16.9 million for the same period in 2005. The increase in R&D expenses reflected the addition of development for cost and quality of care solutions following the December 2005 acquisition of CareKey, as well as

17

continuing investments in our core administration and component software to add new capabilities and functionality for future customer needs. The net increase of $4.3 million was due primarily to higher compensation costs impacted by our annual merit increases in early 2006, increased headcount and the adoption of SFAS 123R. As a percentage of total revenue, R&D expenses approximated 12% in the first six months of both 2006 and 2005. R&D expenses, as a percentage of total R&D expenditures (which includes capitalized R&D expenses of $4.6 million in the first six months of 2006 and $4.1 million for the same period in 2005), was 82% in the first six months of 2006 and 80% for the same period in 2005.

Selling, General and Administrative (SG&A) Expenses. SG&A expenses increased $8.5 million, or 23%, to $45.4 million in the first six months of 2006 from $36.9 million for the same period in 2005. The overall increase resulted primarily from higher compensation and legal costs and increased investment in infrastructure and technology, partially offset by loss on facility closures recorded in 2005. Higher compensation and related costs of $5.8 million were impacted by our annual merit increases in early 2006, increased recruiting fees related to new hires, and our adoption of SFAS 123R, offset in part by a reassignment of product and development leaders and other executives to more appropriately align their responsibilities with our market facing strategy. The increase in legal fees of $2.6 million was attributable to an increase in litigation defense costs in the first six months of 2006 and a $1.1 million insurance reimbursement related to a legal settlement that occurred in 2005. Investment in infrastructure and technology increased $647,000 for internal support. These costs were offset in part by $1.0 million primarily related to lease termination costs associated with certain facility closures in 2005. As a percentage of total revenue, selling, general and administrative expenses approximated 26% in the first six months of both 2006 and 2005.

Amortization of Other Intangible Assets. Amortization of other intangible assets increased $836,000, or 48%, to $2.6 million in the first six months of 2006 from $1.7 million for the same period in 2005. The increase was due to amortization of identifiable intangible assets acquired through the CareKey acquisition of $2.2 million, offset in part by a decrease due to certain intangible assets acquired in previous years, which were fully amortized in late 2005. Although the CareKey fair market valuation has not yet been finalized, we have booked an estimate based on the preliminary valuation.

Interest Income. Interest income increased $1.5 million, or 395%, to $1.8 million in the first six months of 2006 from $371,000 for the same period in 2005. The increase is due primarily to higher cash balances, as well as higher interest earned in our investment accounts.

Interest Expense. Interest expense increased $1.1 million, or 210%, to $1.7 million in the first six months of 2006 from $537,000 in the same period in 2005. The increase relates primarily to quarterly interest of $688,000 incurred on the $100 million convertible debt, offset in part by a decrease attributable to the IMS Health note payable, which was fully repaid in January 2005.

Other Income. Other income of $180,000 consists of the gain on sale of an internet domain name.

Provision for Income Taxes. Provision for income taxes was $951,000 in the first six months of 2006 compared to $636,000 for the same period in 2005. The provision for income taxes reflects a benefit from state tax refunds received related to prior years for which income tax benefit was not previously recorded, offset partially by an increase in Federal income taxes. Absent this state tax benefit, our effective tax rate would have been 8.7% for the six-month period ended June 30, 2006, which was lower than the Federal statutory rate primarily due to the decrease in valuation allowance, which occurred as a result of projected utilization of net operating loss (“NOLs”) carryovers. The effective tax rate was 6.4% for the six-month period ended June 30, 2005. The increase in the effective tax rate for the six-month period ended June 30, 2006 was due to an increase in the provision for Federal taxes.

LIQUIDITY AND CAPITAL RESOURCES

Capital Resources

Our principal sources of liquidity include cash from operations, employee exercises of stock options, private financings, borrowings under our debt facility, proceeds from a convertible debt transaction and cash obtained from our acquisitions. As of June 30, 2006, we had the following sources of cash available to fund our operations:

• In January 2006, we entered into an amendment to our Credit Agreement established December 21, 2004 to increase the amount of the revolving credit facility from $50 million to $100 million and extend the expiration date of the Credit Agreement to January 5, 2010. As of June 30, 2006, we had outstanding borrowings on the revolving line of credit of $4.0 million and were in compliance with all applicable covenants and other restrictions under the Credit Agreement.

• In October 2005, we issued $100 million aggregate principal amount of 2.75% Convertible Senior Notes due 2025 (the “Notes”). The Notes are convertible into shares of our common stock at an initial conversion price of $18.85

18

per share, or 53.0504 shares for each $1,000 principal amount of Notes, subject to certain adjustments. The Notes bear interest at a rate of 2.75%, which is payable in cash semi-annually.

Based on our current operating plan, we believe that existing cash and cash equivalents balances, cash forecasted by management to be generated by operations and borrowings from existing credit facilities will be sufficient to meet our working capital and capital requirements for at least the next 12 months. However, if events or circumstances occur such that we do not meet our operating plan as expected, we may be required to seek additional capital and/or reduce certain discretionary spending, which could have a material adverse effect on our ability to achieve our business objectives. We may seek additional financing, which may include debt and/or equity financing or funding through third party agreements. There can be no assurance that any additional financing will be available on acceptable terms, if at all. Any equity financing may result in dilution to existing stockholders and any debt financing may include restrictive covenants.

Summary of Cash Activities

As of June 30, 2006, we had cash and cash equivalents totaling $76.5 million, which included $1.0 million in restricted cash. Significant cash flow activities for the six months ended June 30, 2006 and 2005 are as follows (in thousands):

	Six Months Ended June 30,
	2006			2005
Cash provided by operating activities	$	11,569		$	12,925
Sale of short-term investments, net		—			1,203
Purchase of property and equipment and software licenses		(6,252	)		(1,640	)
Capitalization of software development costs		(4,605	)		(4,124	)
Acquisition, net of cash acquired		(42,370	)		—
Proceeds from revolving line of credit and debt financings		19,992			40,511
Payments on revolving line of credit, notes payable and capital leases		(16,700	)		(68,675	)
Employee exercises of stock options and purchase of common stock		6,921			4,118

Cash and cash equivalents decreased $31.4 million in the first six months of 2006 from $106.9 million at December 31, 2005 to $75.5 million at June 30, 2006. This decrease was primarily due to cash payments of $42.4 million related to the acquisition of CareKey. Significant cash inflows during the first six months of 2006 included cash provided by operating activities of $11.6 million and $6.9 million of proceeds from the issuance of common stock related to employee exercises of stock options and purchases of common stock.

Commitments and Contingencies

The following tables summarize our estimated contractual obligations and other commercial commitments (in thousands):

	Payments (including interest) Due by Period
Contractual obligations	Total		Less than 1 Year		1-3 Years		3-5 Years		More than 5 Years
Short-term debt	$	754	$	754	$	—	$	—	$	—
Capital lease obligations		1,703		1,029		535		139		—
Operating leases		68,181		14,668		20,733		13,510		19,270
Convertible debt, including interest		153,656		2,781		5,500		5,500		139,875
Other obligations		1,378		1,378		—		—		—
Total contractual obligations	$	225,588	$	20,526	$	26,768	$	19,149	$	159,145
	Amount of Commitment Expiration per Period
Other commercial commitments	Total Amounts Committed		Less Than 1 Year		1-3 Years		3-5 Years		More than 5 Years
Line of credit	$	4,000	$	—	$	—	$	4,000	$	—
Standby letters of credit		992		100		500		308		84
Total other commercial commitments	$	4,992	$	100	$	500	$	4,308	$	84

19

In the second quarter of 2006, we extended the term of our lease on our Colorado facility for a period of seven years from July 31, 2009 through July 31, 2016. At the same time, we leased an additional 50,862 square feet within this facility. The extension and expansion of this leased facility created a $21.4 million increase in operating lease commitments in the quarter.

Convertible debt represents scheduled principal and interest payments for our October 2005 convertible debt offering, which includes $100 million aggregate principal amount of our Convertible Senior Notes. The Notes bear interest at a rate of 2.75%, which is payable in cash semi-annually in arrears on April 1 and October 1 of each year, commencing on April 1, 2006, to the holders of record on the preceding March 15 and September 15, respectively. The Notes mature on October 1, 2025. However, on or after October 5, 2010, we may from time to time at our option redeem the Notes, in whole or in part, for cash, at the applicable redemption date. Additionally, holders of the Notes may require us to purchase all or a portion of their Notes in cash on each of October 1, 2010, October 1, 2015 and October 1, 2020.

Other obligations includes $1.4 million of estimated payments related to an agreement dated March 8, 2006 to lease space currently occupied. An initial, non-refundable payment of $205,000 was made to the current occupants upon execution of the agreement. The estimated remaining payments of $1.4 million, which include purchase of the existing furnishings, are contingent upon the occupants vacating the space by October 31, 2006. These payments are estimates and may change based on the actual date the occupants vacate.

As of June 30, 2006, we had outstanding four unused standby letters of credit in the aggregate amount of $1.0 million which serve as security deposits for certain capital and operating leases and insurance policies. We are required to maintain a cash balance equal to the outstanding letters of credit, which is classified as restricted cash on our balance sheet.

Excluded from the table above are certain potential payments to CareKey stockholders and optionholders as these payments are contingent upon the achievement of financial milestones and are payable in either cash or stock at our election. CareKey stockholders and optionholders are entitled to receive three contingent consideration payments of $8.3 million each (up to $25.0 million), upon the achievement of certain revenue milestones during the period beginning upon acquisition and ending December 31, 2008. In addition, further consideration payable in cash or stock at our election, may be paid to former CareKey stockholders and optionholders if, prior to December 31, 2008, the acquired CareKey products generate revenues in excess of certain revenue milestones and/or if a negotiated multiple of software maintenance revenues of acquired CareKey products during the fiscal year ended December 31, 2009 exceed total purchase consideration made to those former CareKey stockholders and optionholders.

OFF-BALANCE SHEET ARRANGEMENTS

The Company does not currently have any relationships with unconsolidated entities or financial partnerships, such as entities referred to as structured finance or special purpose entities, which would have been established for the purpose of facilitating off-balance sheet or other contractually narrow or limited purposes.

20

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Market risk associated with adverse changes in financial and commodity market prices and rates could impact our financial position, operating results or cash flows. We are exposed to market risk due to changes in interest rates such as the prime rate and LIBOR. This exposure is directly related to our normal operating and funding activities. Historically, and as of June 30, 2006, we have not used derivative instruments or engaged in hedging activities.

The interest rate on our $100.0 million revolving credit facility is a per annum rate equal to (i) the LIBOR rate plus an applicable margin of between 1.75% and 2.25% or (ii) the lending institution’s prime rate plus an adjustable applicable margin of between 0.0% and 0.5%, at our election, subject to specified restrictions, and is payable monthly in arrears. The revolving credit facility expires in January 2010. As of June 30, 2006, we had outstanding borrowings on the revolving line of credit of $4.0 million.

On September 30, 2005, we entered into a Purchase Agreement with UBS Securities, LLC, Banc of America Securities, LLC and William Blair & Company LLC (the “Initial Purchasers”), to sell $100 million aggregate principal amount of our 2.75% Convertible Senior Notes due 2025 (the “Notes”) in a private placement in reliance on Section 4(2) of the Securities Act of 1933, as amended (the “Securities Act”). The Notes have been resold by the Initial Purchasers to qualified institutional buyers pursuant to Rule 144A under the Securities Act. The sale of the Notes to the Initial Purchasers was consummated on October 5, 2005. The Notes were issued pursuant to an Indenture, dated October 5, 2005, by and between us and Wells Fargo Bank, National Association, as trustee. The Notes bear interest at a rate of 2.75%, which is payable in cash semi-annually in arrears on April 1 and October 1 of each year, commencing on April 1, 2006, to the holders of record on the preceding March 15 and September 15, respectively.

We manage interest rate risk by investing excess funds in cash equivalents and short-term investments bearing variable interest rates, which are tied to various market indices. We also manage interest rate risk by closely managing our borrowings on our credit facility based on our operating needs in order to minimize the interest expense incurred. As a result, we do not believe that near-term changes in interest rates will result in a material effect on our future earnings, fair values or cash flows.

Item 4. Controls and Procedures

Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of our disclosure controls and procedures, as such term is defined under Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Based on this evaluation, our principal executive officer and our principal financial officer concluded that our disclosure controls and procedures were effective as of the end of the period covered by this quarterly report.

Additionally, there were no changes in our internal controls over financial reporting during the quarter ended June 30, 2006 that have materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting.

21

PART II—OTHER INFORMATION

Item 1. Legal Proceedings

In September 2004, McKesson Information Solutions LLC (“McKesson”) filed a lawsuit against us in the United States District Court for the District of Delaware. In its complaint, McKesson alleged that we have made, used, offered for sale, and/or sold a clinical editing software system that infringes McKesson’s United States Patent No. 5,253,164, entitled “System And Method For Detecting Fraudulent Medical Claims Via Examination Of Services Codes.” McKesson seeks injunctive relief and substantial monetary damages, including treble damages for willful infringement. On April 4, 2006, in response to our motion for summary judgment, the court ruled, as a matter of law, that our software products do not infringe 12 of the 15 claims of McKesson’s patent that were involved in this dispute, leaving claims 1, 2 and 16.

On April 17, 2006, a jury trial commenced on the first phase of this case to determine the issue of infringement of the remaining three claims. On April 26, 2006, the jury found that our Facets^®, QicLink^™ and ClaimFacts^® software products infringe claims 1 and 2, but not claim 16 of the patent. On May 4, 2006, the court decided that it would not entertain post-trial motions involving infringement until the second phase of the trial has been completed. The court also scheduled the second phase of the trial to commence on October 3, 2006 on the issues of our validity, estoppel and laches defenses and on the issue of McKesson’s damages, if any.

Since the first phase of the trial, we have been involved in discussions with McKesson to settle this lawsuit. The parties have not yet resolved a number of important issues nor agreed upon a final definitive settlement agreement. Accordingly, there can be no assurance that a settlement will be achieved. The parties, however, have discussed certain terms of a potential settlement, whereby we would pay McKesson a royalty fee to allow our existing customers to continue to use our clinical editing software without interruption. The potential settlement also would clarify the manner in which our clinical editing software may or may not be used in future sales. In the event the parties enter into a settlement agreement prior to the second phase of the trial requiring us to pay McKesson a royalty fee, payment of this fee in the amount currently being discussed would not be expected to materially affect our overall financial position or ability to fund future operations. Such amount, however, would have a material adverse impact on our 2006 results of operations and cash flows.

As of the filing of this quarterly report on Form 10-Q, we did not accrue any liability related to this lawsuit as we did not believe at such time that our liability to McKesson is considered probable and can be reasonably estimated. Our attorney fees and other defense costs related to this matter are being expensed as incurred. If we do not prevail on certain of our defenses at the second phase of the trial and the injunction sought by McKesson is granted by the Court, we could be liable for substantial monetary damages and be precluded from offering all or a portion of our clinical editing software to our customers. In addition, pursuant to contractual obligations with many of our Facts^™, Facets^® and QicLink^™ customers, we may be required, at our cost, to replace all or a portion of our clinical editing software with a non-infringing alternative solution. An adverse decision in this litigation could have a material adverse effect on our results of operations, financial position and/or cash flows.

In addition to the matter described above, we are involved in litigation from time to time relating to claims arising out of our operations in the normal course of business. Except as discussed above, as of the filing date of this quarterly report on Form 10-Q, we were not a party to any other legal proceedings, the adverse outcome of which, in management’s opinion, individually or in the aggregate, would have a material adverse effect on our results of operations, financial position and/or cash flows.

22

Item 1A. Risk Factors

Cautionary Statement

This report, and other documents and statements provided or made by us, contain forward-looking statements that have been made pursuant to the provisions of the Private Securities Litigation Reform Act of 1995. These statements may include statements about our future revenues, profits, results, the market for our products and services, future service offerings, industry trends, client and partner relationships, our operational capabilities, future financial structure and uses of cash or proposed transactions. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “forecasts,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” or “continue” or the negative of such terms and other comparable terminology. These statements are only predictions. Actual events or results may differ materially. In evaluating these statements, you should specifically consider various factors, including the following risks:

We cannot predict if we will be able to sustain our positive net income.

We may not be able to sustain our current level of revenue or increase our revenue in the future. We currently derive our revenue primarily from providing hosted solutions, software licensing and maintenance, and other services such as consulting. We depend on the continued demand for healthcare information technology and related services. We plan to continue investing in administrative infrastructure, research and development, sales and marketing, and acquisitions. If we are not able to sustain our current levels of revenue or maintain our profitability, our operations may be adversely affected.

Revenue from a limited number of customers comprises a significant portion of our total revenue, and if these customers terminate or modify existing contracts or experience business difficulties, it could adversely affect our earnings.

As of June 30, 2006, we were providing services to 290 unique customers. One of our customers, The Regence Group, represented approximately 10% of our consolidated revenue for the six months ended June 30, 2006.

Although we typically enter into multi-year customer agreements, a majority of our customers are able to reduce or cancel their use of our services before the end of the contract term, subject to monetary penalties. We also provide services to some hosted customers without long-term contracts. In addition, many of our contracts are structured so that we generate revenue based on units of volume, which include the number of members, number of workstations or number of users. If our customers experience business difficulties and the units of volume decline or if a customer ceases operations for any reason, we will generate less revenue under these contracts and our operating results may be materially and adversely impacted.

Our operating expenses are relatively fixed and cannot be reduced on short notice to compensate for unanticipated contract cancellations or reductions. As a result, any termination, significant reduction or modification of our business relationships with any of our significant customers could have a material adverse effect on our business, financial condition, operating results and cash flows.

Our business is changing rapidly, which could cause our quarterly operating results to vary and our stock price to fluctuate.

Our quarterly operating results have varied in the past, and we expect that they will continue to vary in future periods. Our quarterly operating results can vary significantly based on a number of factors, such as:

• our mix of non-recurring and recurring revenue;

• our ability to add new customers and renew existing accounts;

• selling additional products and services to existing customers;

• long and unpredictable sales cycles;

• meeting project milestones and customer expectations;

• seasonality in information technology purchases;

23

• the timing of new customer sales; and

• general economic conditions.

Variations in our quarterly operating results could cause us to not meet the earnings estimates of securities analysts or the expectations of our investors, which could affect the market price of our common stock in a manner that may be unrelated to our long-term operating performance.

We base our expense levels in part upon our expectations concerning future revenue, and these expense levels are relatively fixed in the short-term. If we do not achieve our expected revenue targets, we may not be able to reduce our short-term spending in response. Any shortfall in revenue would have a direct impact on our results of operations.

The intensifying competition we face from both established entities and new entries in the market may adversely affect our revenue and profitability.

The market for our technology and services is highly competitive and rapidly changing and requires potentially expensive technological advances. Many of our competitors and potential competitors have significantly greater financial, technical, product development, marketing and other resources, and greater market recognition than we have. Many of our competitors also have, or may develop or acquire, substantial installed customer bases in the healthcare industry. As a result, our competitors may be able to respond more quickly to new or emerging technologies and changes in customer requirements or to devote greater resources to the development, promotion, and sale of their applications or services than we can devote.

Our competitors can be categorized as follows:

• information technology and outsourcing companies, such as Perot Systems Corporation, IBM, Affiliated Computer Services, Computer Sciences Corporation, and Electronic Data Systems Corporation;

• healthcare information software vendors, such as Quality Care Solutions, Inc., and Amisys Synertech Inc.;

• healthcare information technology consulting firms, such as First Consulting Group, Inc., Superior Consultant Holdings Corporation and the consulting divisions or former affiliates of the major accounting firms, such as Deloitte Consulting and Accenture;

• healthcaree-commerce and portal companies, such as Emdeon Corporation (formerly WebMD Corporation), NaviMedix and HealthTrio;

• enterprise application integration vendors such as Vitria, SeeBeyond, TIBCO, Fuego and M2; and

• care management software and service companies such as HealthTrio, Electronic Data Systems Corporation, MEDecision, McKesson, WebMD, Perot Systems Corporation, HealthAtoZ and Click4Care.

In addition, some of our third party software vendors may compete with us from time to time by offering their software on a licensed or hosted basis. Further, other entities that do not presently compete with us may do so in the future, including major software information systems companies, financial services entities, or health plans.

We believe our ability to compete will depend in part upon our ability to:

• maintain and continue to develop partnerships with vendors;

• enhance our current technology and services;

• respond effectively to technological changes;

• introduce new technologies; and

• meet the increasingly sophisticated needs of our customers.

Increased competition may result in price reductions, reduced gross margins, and loss of market share, any of which could have a material adverse effect on our results of operations. In addition, pricing, gross margin, and market share could

24

be negatively impacted further as a greater number of available products in the marketplace increases the likelihood that product and service offerings in our markets become more fungible and price sensitive.

Our sales and implementation cycles are long and unpredictable.

We have experienced and continue to experience long and unpredictable sales cycles, particularly for contracts with large customers, or customers purchasing multiple products and services. Enterprise software typically requires significant capital expenditures by customers, and the decision to outsource IT-related services is complicated and time-consuming. Major purchases by large payer organizations typically range from 9 to 12 months or more from initial contact to contract execution. The prospects currently in our pipeline may not sign contracts within a reasonable period of time or at all.

In addition, our implementation cycle has ranged from 12 to 24 months or longer from contract execution to completion of implementation. During the sales cycle and the implementation cycle, we will expend substantial time, effort, and financial resources preparing contract proposals, negotiating the contract, and implementing the solution. We may not realize any revenue to offset these expenditures, and, if we do, accounting principles may not allow us to recognize the revenue during corresponding periods, which could harm our future operating results. Additionally, any decision by our customers to delay implementation may adversely affect our revenues.

Consolidation of healthcare payer organizations and benefits administrators could decrease the number of our existing and potential customers.

There has been and continues to be acquisition and consolidation activity among healthcare payers and benefits administrators. Mergers or consolidations of payer organizations in the future could decrease the number of our existing and potential customers. The acquisition of a customer could reduce our revenue and have a negative impact on our results of operation and financial condition. A smaller overall market for our products and services could also result in lower revenue and margins. In addition, healthcare payer organizations are increasing their focus on consumer directed healthcare, in which consumers interact directly with health plans through administrative services provided by health plans to employer groups. These services compete with the services provided by benefits administrators and could result in additional consolidation in the benefits administration market.

Some of our significant customers may develop their own software solutions, which could decrease the demand for our products.

Some of our customers in the healthcare payer industry have, or may seek to acquire, the financial and technological resources necessary to develop software solutions to perform the functions currently serviced by our products and services. Additionally, consolidation in the healthcare payer industry could result in additional organizations having the resources necessary to develop similar software solutions. If these organizations successfully develop and utilize their own software solutions, they may discontinue their use of our products or services, which could materially and adversely affect our results of operations.

We depend on our software application vendor relationships, and if our software application vendors terminate or modify existing contracts or experience business difficulties, or if we are unable to establish new relationships with additional software application vendors, it could harm our business.

We depend, and will continue to depend, on our licensing and business relationships with third-party software application vendors. Our success depends significantly on our ability to maintain our existing relationships with our vendors and to build new relationships with other vendors in order to enhance our services and application offerings and remain competitive. Although most of our licensing agreements are perpetual or automatically renewable, they are subject to termination in the event that we materially breach such agreements. We may not be able to maintain relationships with our vendors or establish relationships with new vendors. The software, products or services of our third-party vendors may not achieve or maintain market acceptance or commercial success. Accordingly, our existing relationships may not result in sustained business partnerships, successful product or service offerings or the generation of significant revenue for us.

Our arrangements with third-party software application vendors are not exclusive. These third-party vendors may not regard our relationships with them as important to their own respective businesses and operations. They may reassess their commitment to us at any time and may choose to develop or enhance their own competing distribution channels and product support services. If we do not maintain our existing relationships or if the economic terms of our business relationships change, we may not be able to license and offer these services and products on commercially reasonable terms or at all. Our inability to obtain any of these licenses could delay service development or timely introduction of new services and divert our

25

resources. Any such delays could materially adversely affect our business, financial condition, operating results and cash flows.

Our licenses for the use of third-party software applications are essential to the technology solutions we provide for our customers. Loss of any one of our major vendor agreements may have a material adverse effect on our business, financial condition, operating results and cash flows.

We rely on third-party software vendors for components of our software products.

Our software products contain components developed and maintained by third-party software vendors, and we expect that we may have to incorporate software from third-party vendors in our future products. We may not be able to replace the functions provided by the third-party software currently offered with our products if that software becomes obsolete, defective, or incompatible with future versions of our products or is not adequately maintained or updated. Any significant interruption in the availability of these third-party software products or defects in these products could harm the sale of our products unless and until we can secure or develop an alternative source. Although we believe there are adequate alternate sources for the technology currently licensed to us, such alternate sources may not be available to us in a timely manner, may not provide us with the same functions as currently provided to us or may be more expensive than products we currently use.

We have sustained rapid growth, and our inability to manage this growth could harm our business.

We have rapidly and significantly expanded our operations since inception and may continue to do so in the future. This growth has placed, and may continue to place, a significant strain on our managerial, operational, and financial resources, and information systems. If we are unable to manage our growth effectively, it could have a material adverse effect on our business, financial condition, operating results, and cash flows.

Our acquisition strategy may disrupt our business and require additional financing.

Since inception, we have made eight acquisitions. A significant portion of our historical growth has occurred through acquisitions and we may continue to seek strategic acquisitions as part of our growth strategy. We compete with other companies to acquire businesses, making it difficult to acquire suitable companies on favorable terms or at all. Acquisitions may require significant capital, typically entail many risks, and can result in difficulties integrating operations, personnel, technologies, products and information systems of acquired businesses.

We may be unable to successfully integrate companies that we have acquired or may acquire in the future in a timely manner. If we are unable to successfully integrate acquired businesses, we may incur substantial costs and delays or other operational, technical or financial problems. In addition, the integration of our acquisitions may divert our management’s attention from our existing business, which could damage our relationships with our key customers and employees.

To finance future acquisitions, we may issue equity securities that could be dilutive to our stockholders. We may also incur debt and additional amortization expenses related to goodwill and other intangible assets as a result of acquisitions. The interest expense related to this debt and additional amortization expense may significantly reduce our profitability and have a material adverse effect on our business, financial condition, operating results and cash flows. Acquisitions may also result in large one-time charges as well as goodwill and intangible assets and impairment charges in the future that could negatively impact our operating results.

Our need for additional financing is uncertain as is our ability to raise capital if required.

If we are not able to sustain our positive net income, we may need additional financing to fund operations or growth. We may not be able to raise additional funds through public or private financings at any particular point in the future or on favorable terms. Future financings could adversely affect our common stock and debt securities.

Our business will suffer if our software products contain errors.

The proprietary and third party software products we offer are inherently complex. Despite our testing and quality control procedures, errors may be found in current versions, new versions or enhancements of our products. Significant technical challenges may also arise with our products because our customers purchase and deploy those products across a variety of computer platforms and integrate them with a number of third-party software applications and databases. If new or existing customers have difficulty deploying our products or require significant amounts of customer support, our costs

26

would increase. Moreover, we could face possible claims and higher development costs if our software contains undetected errors or if we fail to meet our customers’ expectations. As a result of the foregoing, we could experience:

• loss of or delay in revenue and loss of market share;

• loss of customers;

• damage to our reputation;

• failure to achieve market acceptance;

• diversion of development resources;

• increased service and warranty costs;

• legal actions by customers against us which could, whether or not successful, increase costs and distract our management; and

• increased insurance costs.

We could lose customers and revenue if we fail to meet contractual obligations including performance standards and other material obligations.

Many of our service agreements contain performance standards and other post contract obligations. Our failure to meet these standards or breach other material obligations under our agreements could trigger remedies for our customers including termination, financial penalties and refunds that could have a material adverse effect on our business, financial condition, operating results and cash flows.

If our ability to expand our network and computing infrastructure is constrained in any way, we could lose customers and damage our operating results.

We must continue to expand and adapt our network and technology infrastructure to accommodate additional users, increased transaction volumes, changing customer requirements and technological obsolescence. We may not be able to accurately project the rate or timing of increases, if any, in the use of our hosted solutions or be able to expand and upgrade our systems and infrastructure to accommodate such increases. We may be unable to expand or adapt our network infrastructure to meet additional demand or our customers’ changing needs on a timely basis, at a commercially reasonable cost or at all. Our current information systems, procedures and controls may not continue to support our operations while maintaining acceptable overall performance and may hinder our ability to exploit the market for healthcare applications and services. Service lapses could cause our users to switch to the services of our competitors, which could have a material adverse effect on our business, financial condition, operating results and cash flows.

Performance or security problems with our systems could damage our business.

Our customers’ satisfaction and our business could be harmed if we, or our customers, experience any system delays, failures, or loss of data.

Although we devote substantial resources to avoid performance problems, errors may occur. Errors in the processing of customer data may result in loss of data, inaccurate information, and delays. Such errors could cause us to lose customers and be liable for damages. We currently process a substantial number of our customers’ transactions and data at our data centers in Colorado. Although we have safeguards for emergencies and we have contracted backup processing for our customers’ critical functions, the occurrence of a major catastrophic event or other system failure at any of our facilities could interrupt data processing or result in the loss of stored data. In addition, we depend on the efficient operation of telecommunication providers that have had periodic operational problems or experienced outages.

A material security breach could damage our reputation or result in liability to us. We retain confidential customer and federally protected patient information in our data centers. Therefore, it is critical that our facilities and infrastructure remain secure and that our facilities and infrastructure are perceived by the marketplace to be secure. Despite the implementation of security measures, our infrastructure may be vulnerable to physical break-ins, computer viruses, programming errors, attacks by third parties, or similar disruptive problems.

27

Our services agreements generally contain limitations on liability, and we maintain insurance with coverage limits of $26 million for general liability and $20 million for professional liability to protect against claims associated with the use of our products and services. However, the contractual provisions and insurance coverage may not provide adequate coverage against all possible claims that may be asserted. In addition, appropriate insurance may be unavailable in the future at commercially reasonable rates. A successful claim in excess of our insurance coverage could have a material adverse effect on our business, financial condition, operating results, and cash flows. Even unsuccessful claims could result in litigation or arbitration costs and may divert management’s attention from our existing business.

Our success depends on our ability to attract, retain and motivate management and other key personnel.

Our success will depend in large part on the continued services of management and key personnel. Competition for personnel in the healthcare information technology market is intense, and there are a limited number of persons with knowledge of, and experience in, this industry. We do not have employment agreements with most of our executive officers, so any of these individuals may terminate his or her employment with us at any time. The loss of services from one or more of our management or key personnel, or the inability to hire additional management or key personnel as needed, could have a material adverse effect on our business, financial condition, operating results, and cash flows. Although we currently experience relatively low rates of turnover for our management and key personnel, the rate of turnover may increase in the future. In addition, we expect to further grow our operations and our needs for additional management and key personnel will increase. Our continued ability to compete effectively in our business depends on our ability to attract, retain, and motivate these individuals.

We rely on an adequate supply and performance of computer hardware and related equipment from third parties to provide services to larger customers and any significant interruption in the availability or performance of third-party hardware and related equipment could adversely affect our ability to deliver our products to certain customers on a timely basis.

As we offer our hosted solution services and software to a greater number of customers and particularly to larger customers, we may be required to obtain specialized computer equipment from third parties that can be difficult to obtain on short notice. Any delay in obtaining such equipment may prevent us from delivering large systems to our customers on a timely basis. We also may rely on such equipment to meet required performance standards. We may have no control over the resources that third parties may devote to service our customers or satisfy performance standards. If such performance standards are not met, we may be adversely impacted under our service agreements with our customers.

Any failure or inability to protect our technology and confidential information could adversely affect our business.

Our success depends in part upon proprietary software and other confidential information. The software and information technology industries have experienced widespread unauthorized reproduction of software products and other proprietary technology. We rely on a combination of copyright, patent, trademark and trade secret laws, confidentiality procedures, and contractual provisions to protect our intellectual property. However, these protections may not be sufficient, and they do not prevent independent third-party development of competitive products or services.

We execute confidentiality and non-disclosure agreements with certain employees and our suppliers, as well as limit access to and distribution of our proprietary information. The departure of any of our management and technical personnel, the breach of their confidentiality and non-disclosure obligations to us, or the failure to achieve our intellectual property objectives could have a material adverse effect on our business, results of operations and financial condition. We have had, and may continue to have, employees leave us and go to work for competitors. If we are not successful in prohibiting the unauthorized use of our proprietary technology or the use of our processes by a competitor, our competitive advantage may be significantly reduced which would result in reduced revenues.

Our products may infringe the intellectual property rights of others, which may cause us to incur unexpected costs or prevent us from selling our products.

We cannot be certain that our products do not infringe issued patents or other intellectual property rights of others. In addition, because patent applications in the United States and many other countries are not publicly disclosed until a patent is issued, applications covering technology used in our software products may have been filed without our knowledge. We may be subject to legal proceedings and claims from time to time, including claims of alleged infringement of the patents, trademarks and other intellectual property rights of third parties by us or our licensees in connection with their use of our products. Intellectual property litigation is expensive and time-consuming and could divert our management’s attention away

28

from running our business and seriously harm our business. If we were to discover that our products violated the intellectual property rights of others, we would have to obtain licenses from these parties in order to continue marketing our products without substantial reengineering. We might not be able to obtain the necessary licenses on acceptable terms or at all, and if we could not obtain such licenses, we might not be able to reengineer our products successfully or in a timely fashion. If we fail to address any infringement issues successfully, we would be forced to incur significant costs, including damages and potentially satisfying indemnification obligations that we have with our customers, and we could be prevented from selling certain of our products.

Currently, we are a party to a lawsuit filed against us by McKesson Information Solutions LLC in the United States District Court for the District of Delaware alleging that we have made, used, offered for sale, and/or sold a system that infringes McKesson’s United States Patent No. 5,253,164, entitled “System And Method For Detecting Fraudulent Medical Claims Via Examination Of Services Codes.” McKesson seeks injunctive relief and monetary damages, including treble damages for willful infringement. An adverse decision in this litigation could have a material adverse effect on our results of operations, financial condition and/or cash flows.

If our consulting services revenue does not grow substantially, our revenue growth could be adversely impacted.

Our consulting services revenue represents a significant component of our total revenue and we anticipate that it will continue to represent a significant percentage of total revenue in the future. The level of consulting services revenue depends upon the healthcare industry’s demand for outsourced information technology services and our ability to deliver products that generate implementation and follow-on consulting services revenue. Our ability to increase services revenue will depend in part on our ability to increase the capacity of our consulting group, including our ability to recruit, train and retain a sufficient number of qualified personnel.

The insolvency of our customers or the inability of our customers to pay for our services could negatively affect our financial condition.

Healthcare payers are often required to maintain restricted cash reserves and satisfy strict balance sheet ratios promulgated by state regulatory agencies. In addition, healthcare payers are subject to risks that physician groups or associations within their organizations become subject to costly litigation or become insolvent, which may adversely affect the financial stability of the payer. If healthcare payers are unable to pay for our services because of their need to maintain cash reserves or failure to maintain balance sheet ratios or solvency, our ability to collect fees for services rendered would be impaired and our financial condition could be adversely affected.

Changes in government regulation of the healthcare industry could adversely affect our business.

During the past several years, the healthcare industry has been subject to increasing levels of government regulation of, among other things, reimbursement rates and certain capital expenditures. In addition, proposals to substantially reform Medicare, Medicaid, and the healthcare system in general have been or are being considered by Congress. These proposals, if enacted, may further increase government involvement in healthcare, lower reimbursement rates, and otherwise adversely affect the healthcare industry which could adversely impact our business. The impact of regulatory developments in the healthcare industry is complex and difficult to predict, and our business could be adversely affected by existing or new healthcare regulatory requirements or interpretations.

Participants in the healthcare industry, such as our payer customers, are subject to extensive and frequently changing laws and regulations, including laws and regulations relating to the confidential treatment and secure transmission of patient medical records, and other healthcare information. Legislators at both the state and federal levels have proposed and enacted additional legislation relating to the use and disclosure of medical information, and the federal government is likely to enact new federal laws or regulations in the near future. Pursuant to the Health Insurance Portability and Accountability Act of 1996 (“HIPAA”), the Department of Health and Human Services (“DHHS”) has issued a series of regulations setting forth security, privacy and transactions standards for all health plans, clearinghouses, and healthcare providers to follow with respect to individually identifiable health information. DHHS has issued final regulations mandating the use of standard transactions and code sets, which became effective October 16, 2003. DHHS has also issued final HIPAA privacy regulations, which required Covered Entities to be in compliance by April 14, 2003, and final HIPAA security regulations, which required Covered Entities to be in compliance by April 20, 2005. Many of our customers will also be subject to state laws implementing the federal Gramm-Leach-Bliley Act, relating to certain disclosures of nonpublic personal health information and nonpublic personal financial information by insurers and health plans.

29

Our payer customers must comply with HIPAA, its regulations, and other applicable healthcare laws and regulations. In addition, we may be deemed to be a covered entity subject to HIPAA because we offer our customers products that convert data to a HIPAA compliant format. Accordingly, we must comply with certain provisions of HIPAA and in order for our products and services to be marketable, they must contain features and functions that allow our customers to comply with HIPAA and other healthcare laws and regulations. We believe our products currently allow our customers to comply with existing laws and regulations. However, because HIPAA and its regulations have yet to be fully interpreted, our products may require modification in the future. If we fail to offer solutions that permit our customers to comply with applicable laws and regulations, our business will suffer.

We perform billing and claims services that are governed by numerous federal and state civil and criminal laws. The federal government in recent years has imposed heightened scrutiny on billing and collection practices of healthcare providers and related entities, particularly with respect to potentially fraudulent billing practices, such as submissions of inflated claims for payment and upcoding. Violations of the laws regarding billing and coding may lead to civil monetary penalties, criminal fines, imprisonment, or exclusion from participation in Medicare, Medicaid and other federally funded healthcare programs for our customers and for us. Any of these results could have a material adverse effect on our business, financial condition, operating results, and cash flows.

In addition, laws governing healthcare payers are often not uniform among states. This could require us to undertake the expense and difficulty of tailoring our products in order for our customers to be in compliance with applicable state and local laws and regulations.

Part of our business is subject to government regulation relating to the Internet that could impair our operations.

The Internet and its associated technologies are subject to increasing government regulation. A number of legislative and regulatory proposals are under consideration by federal, state, local, and foreign governments, and agencies. Laws or regulations may be adopted with respect to the Internet relating to liability for information retrieved from or transmitted over the Internet, on-line content regulation, user privacy, taxation and quality of products and services. Many existing laws and regulations, when enacted, did not anticipate the methods of the Internet-based hosted, software and information technology solutions we offer. We believe, however, that these laws may be applied to us. We expect our products and services to be in substantial compliance with all material federal, state and local laws and regulations governing our operations. However, new legal requirements or interpretations applicable to the Internet could decrease the growth in the use of the Internet, limit the use of the Internet for our products and services or prohibit the sale of a particular product or service, increase our cost of doing business, or otherwise have a material adverse effect on our business, results of operations and financial conditions. To the extent that we market our products and services outside the United States, the international regulatory environment relating to the Internet and healthcare services could also have an adverse effect on our business.

Increased leverage as a result of our convertible note offering may harm our financial condition and results of operations.

On October 5, 2005, we completed a private placement of $100 million aggregate principal amount of our 2.75% Convertible Senior Notes due 2025 (“Notes”). The indebtedness under the Notes constitutes senior unsecured obligations and will rank equally with all of our existing and future unsecured indebtedness. The Notes were issued pursuant to an Indenture dated October 5, 2005 (the “Indenture”) with Wells Fargo Bank, National Association, as trustee.

As of June 30, 2006, our total consolidated long-term debt was $104.7 million. In addition, the Indenture does not restrict our ability to incur additional indebtedness, and we may choose to incur additional debt in the future. Our level of indebtedness could have important consequences to you, because:

• it could affect our ability to satisfy our debt obligations under the Notes or our credit facility;

• a substantial portion of our cash flows from operations will have to be dedicated to interest and principal payments of our debt obligations and may not be available for operations, expansion, acquisitions or other purposes;

• it may impair our ability to obtain additional financing in the future;

• it may limit our flexibility in planning for, or reacting to, changes in our business and industry; and

• it may make us more vulnerable to downturns in our business, our industry or the economy in general.

30

Our ability to make payments of principal and interest on our indebtedness depends upon our future performance, which will be subject to our success in marketing our products and services, general economic conditions and financial, business and other factors affecting our operations, many of which are beyond our control. If we are not able to generate sufficient cash flow from operations in the future to service our indebtedness, we may be required, among other things:

• to seek additional financing in the debt or equity markets;

• to refinance or restructure all or a portion of our indebtedness;

• to sell assets; and/or

• to reduce or delay planned expenditures on research and development and/or commercialization activities.

Such measures might not be sufficient to enable us to service our debt. In addition, any such financing, refinancing or sale of assets might not be available on economically favorable terms or at all.

We have certain repurchase and payment obligations under the Notes and we may not be able to repurchase such Notes or pay the amounts due upon conversion of the Notes when necessary.

On each of October 1, 2010, 2015 and 2020, holders of certain of the Notes may require us to purchase, for cash, all or a portion of their Notes at 100% of their principal amount, plus any accrued and unpaid interest. If a fundamental change occurs, as defined in the Indenture, including a change in control transaction, holders of such Notes may also require us to repurchase, for cash, all or a portion of their Notes. In addition, upon conversion of such Notes if we have made an irrevocable election to settle conversion in cash, we would be required to satisfy our conversion obligation up to the principal amount of the Notes in cash. Our ability to repurchase the Notes and settle the conversion of the Notes in cash is effectively subordinated to our senior credit facility and may be limited by law, by the Indenture, by the terms of other agreements relating to our senior debt and by indebtedness and agreements that we may enter into in the future which may replace, supplement or amend our existing or future debt. Our failure to repurchase the Notes or make the required payments upon conversion would constitute an event of default under the Indenture, which would in turn constitute a default under the terms of our senior credit facility and other indebtedness at that time.

Our common stock price has been, and may continue to be, volatile and our shareholders may not be able to resell shares of our stock at or above the price paid for such shares.

The price for shares of our common stock has exhibited high levels of volatility with significant volume and price fluctuations, which makes our common stock unsuitable for many investors. For example, for the year ended December 31, 2005, the closing price of our common stock ranged from a high of $17.33 to a low of $8.05. The fluctuations in price of our common stock have occasionally been related to our operating performance. These broad fluctuations may negatively impact the market price of shares of our common stock. The price of our common stock has also been influenced by:

• fluctuations in our results of operations or the operations of our competitors or customers;

• failure of our results of operations to meet the expectations of stock market analysts and investors;

• changes in stock market analyst recommendations regarding us, our competitors or our customers; and

• the timing and announcements of new products or financial results by us or our competitors;

Future issuances of common stock may depress the trading price of our common stock.

Any future issuance of equity securities, including the issuance of shares upon conversion of the Notes, could dilute the interests of our existing stockholders and could substantially decrease the trading price of our common stock. We may issue equity securities in the future for a number of reasons, including to finance our operations and business strategy, to adjust our ratio of debt to equity, to satisfy our obligations upon the exercise of outstanding warrants or options or for other reasons.

31

Our stockholder rights plan and charter documents could make it more difficult for a third party to acquire us, even if doing so would be beneficial to our shareholders.

Our stockholder rights plan and certain provisions of our certificate of incorporation and Delaware law are intended to encourage potential acquirers to negotiate with us and allow our Board of Directors the opportunity to consider alternative proposals in the interest of maximizing shareholder value. However, such provisions may also discourage acquisition proposals or delay or prevent a change in control, which in turn, could harm our stock price.

Item 4. Submission of Matters to a Vote of Security Holders

The Company’s 2006 Annual Meeting of Stockholders (the “Annual Meeting”) was held on May 22, 2006. At the Annual Meeting, the Company’s stockholders: (a) elected two Class I Directors with terms expiring at the 2009 Annual Meeting of Stockholders; (b) approved amendments to our 1998 Long-Term Incentive Plan; and (c) ratified the appointment of Ernst & Young LLP as our independent registered public accountants for the year ending December 31, 2006.

Following the Annual Meeting, three Class II Directors, having terms expiring in 2007, and two Class III Directors, having terms expiring in 2008, continued in office.

The following table sets forth the results of voting at the Annual Meeting:

Matter	For	Against	Abstentions	Broker Non-Votes
Election of Directors for a term expiring at the 2009 Annual Meeting of Stockholders*
•      Paul F. LeFort	37,363,231	1,172,845	*	*
•      Jerry P. Widman	35,310,468	3,225,608	*	*
Approval of amendments to 1998 Long-Term Incentive Plan	24,930,812	8,220,752	416,036	4,968,476
Ratification of appointment of Ernst & Young LLP as independent registered public accountants for 2006	38,491,913	42,982	1,181	0

* With respect to the election of directors, the form of proxy permitted stockholders to check boxes indicating votes either “For All” or “Withhold Authority,” or to vote “For All Except” and to name exceptions; votes relating to directors designated above as “Against” include votes cast as “Withhold Authority” and for named exceptions.

32

Item 6. Exhibits

The following exhibits are filed as part of this report:

EXHIBIT NUMBER	DESCRIPTION
10.1*	Amended Cash Bonus Plan (Incorporated by reference to Exhibit 10.1 of TriZetto’s Form 8-K as filed with the SEC on May 15, 2006, File No. 000-27501)
31.1	Certification of CEO Pursuant to Securities Exchange Act Rules 13a-14 and 15d-14 as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2	Certification of CFO Pursuant to Securities Exchange Act Rules 13a-14 and 15d-14 as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1	Certification of CEO and CFO Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

* Previously filed.

33

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	THE TRIZETTO GROUP, INC.
Date: August 7, 2006	By:	/s/ JAMES C. MALONE
		James C. Malone
		(Principal Financial Officer and Duly Authorized Officer)

34

EXHIBIT INDEX

EXHIBIT NUMBER	DESCRIPTION
10.1*	Amended Cash Bonus Plan (Incorporated by reference to Exhibit 10.1 of TriZetto’s Form 8-K as filed with the SEC on May 15, 2006, File No. 000-27501)
31.1	Certification of CEO Pursuant to Securities Exchange Act Rules 13a-14 and 15d-14 as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2	Certification of CFO Pursuant to Securities Exchange Act Rules 13a-14 and 15d-14 as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1	Certification of CEO and CFO Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

* Previously filed.

35